Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stem Cell Research

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 722 articles:
HTML format



Single Articles


    July 2021
  1. LEW TE, Cliff ERS, Dickinson M, Tam CS, et al
    T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.
    Bone Marrow Transplant. 2021 Jul 20. pii: 10.1038/s41409-021-01418.
    PubMed    


  2. KANG HM, Kim SK, Ryu IH, Lee JW, et al
    Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
    PubMed     Abstract available


  3. ZUCENKA A, Vaitekenaite V, Maneikis K, Davainis L, et al
    Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01416.
    PubMed     Abstract available


  4. ABO S, Ritchie D, Denehy L, Panek-Hudson Y, et al
    Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study.
    Bone Marrow Transplant. 2021 Jul 16. pii: 10.1038/s41409-021-01411.
    PubMed     Abstract available


  5. JENTZSCH M, Grimm J, Bill M, Kupper J, et al
    Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01407.
    PubMed    


  6. KONDO G, Ishimaru F, Konuma T, Takahashi S, et al
    Cord blood index predicts engraftment and early non-relapse mortality in adult patients with single-unit cord blood transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01406.
    PubMed     Abstract available


  7. CUVELIER S, Blaise D, Boher JM, Villaron-Goetgheluck C, et al
    A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 14. pii: 10.1038/s41409-021-01401.
    PubMed     Abstract available


  8. LUFT T, Dreger P, Radujkovic A
    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01390.
    PubMed     Abstract available


  9. ALARCON TOMAS A, Whiting K, Maloy M, Ruiz JD, et al
    The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01392.
    PubMed     Abstract available


  10. BORTNICK R, Wlodarski M, de Haas V, De Moerloose B, et al
    Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Jul 9. pii: 10.1038/s41409-021-01374.
    PubMed     Abstract available


  11. TANG FF, Zhao XY, Huo MR, Chang YJ, et al
    Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.
    Bone Marrow Transplant. 2021 Jul 8. pii: 10.1038/s41409-021-01382.
    PubMed     Abstract available


  12. COSTA TCM, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, et al
    Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01365.
    PubMed     Abstract available


  13. LANKESTER AC, Albert MH, Booth C, Gennery AR, et al
    EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01378.
    PubMed    


  14. BAA AK, Chellapuram SK, Sharma A, Malik PS, et al
    Poems syndrome: consolidation with autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01395.
    PubMed    


  15. PRYCE A, Mir F, Ushiro-Lumb I, Drypen R, et al
    SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01379.
    PubMed    


  16. LIU L, Miao M, Chen X, Zhang Y, et al
    Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01398.
    PubMed    


  17. WOLFF D, Fatobene G, Rocha V, Kroger N, et al
    Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01389.
    PubMed     Abstract available


  18. ANSARI M, Petrykey K, Rezgui MA, Del Vecchio V, et al
    Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT.
    Bone Marrow Transplant. 2021 Jul 2. pii: 10.1038/s41409-021-01386.
    PubMed     Abstract available


  19. LUCIA A, Fiuza-Luces C
    Physical fitness and childhood hematopoietic stem cell transplantation: a call to action.
    Bone Marrow Transplant. 2021 Jul 1. pii: 10.1038/s41409-021-01397.
    PubMed    


    June 2021
  20. LUPO-STANGHELLINI MT, Xue E, Mastaglio S, Oltolini C, et al
    COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
    Bone Marrow Transplant. 2021 Jun 30. pii: 10.1038/s41409-021-01278.
    PubMed    


  21. LEMIEUX C, Muffly LS, Iberri DJ, Craig JK, et al
    Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
    Bone Marrow Transplant. 2021 Jun 23. pii: 10.1038/s41409-021-01371.
    PubMed     Abstract available


  22. GILFANOVA R, Callegari A, Childs A, Yang G, et al
    A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01368.
    PubMed     Abstract available


  23. FRIDH MK, Simonsen C, Schmidt-Andersen P, Nissen AA, et al
    Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01370.
    PubMed     Abstract available


  24. BERGERON A
    Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions!
    Bone Marrow Transplant. 2021 Jun 18. pii: 10.1038/s41409-021-01381.
    PubMed    


  25. FERNANDEZ-SOJO J, Azqueta C, Valdivia E, Martorell L, et al
    Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
    Bone Marrow Transplant. 2021 Jun 14. pii: 10.1038/s41409-021-01367.
    PubMed     Abstract available


  26. BONIFAZI F, Defrancesco I, Olivieri J, Barbato F, et al
    Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01359.
    PubMed    


  27. FLOISAND Y, Schroeder MA, Chevallier P, Selleslag D, et al
    A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01356.
    PubMed     Abstract available


  28. KAWASHIMA N, Nishikawa E, Tsuchisaka A, Hashimoto T, et al
    Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01335.
    PubMed    


    May 2021
  29. ESQUIROL A, Pascual MJ, Kwon M, Perez A, et al
    Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01328.
    PubMed     Abstract available


  30. WAIDHAUSER J, Labopin M, Esteve J, Kroger N, et al
    Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01322.
    PubMed     Abstract available


  31. KUMARI R, Palaniyandi S, Hildebrandt GC
    The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease.
    Bone Marrow Transplant. 2021 May 29. pii: 10.1038/s41409-021-01325.
    PubMed    


  32. SUN X, Yang J, Cai Y, Wan L, et al
    Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation
    Bone Marrow Transplant. 2021 May 25. pii: 10.1038/s41409-021-01358.
    PubMed     Abstract available


  33. GRECO R, Alexander T, Burman J, Del Papa N, et al
    Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01326.
    PubMed     Abstract available


  34. LACY M, Fong M, Bolton C, Maranzano M, et al
    Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01331.
    PubMed     Abstract available


  35. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
    T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
    PubMed     Abstract available


  36. MIKULSKA M, Tridello G, Hoek J, Gil L, et al
    Legionellosis after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 22. pii: 10.1038/s41409-021-01333.
    PubMed     Abstract available


  37. BEAUVERD Y, Morin S, Stephan C, De Ramon Ortiz C, et al
    The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
    Bone Marrow Transplant. 2021 May 18. pii: 10.1038/s41409-021-01334.
    PubMed    


  38. SHIMOMURA Y, Hara M, Konuma T, Itonaga H, et al
    Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients.
    Bone Marrow Transplant. 2021 May 15. pii: 10.1038/s41409-021-01324.
    PubMed     Abstract available


  39. SEO S, Usui Y, Matsuo K, Atsuta Y, et al
    Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2021 May 14. pii: 10.1038/s41409-021-01289.
    PubMed     Abstract available


  40. VIJENTHIRA A, Kuruvilla J, Prica A
    Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01327.
    PubMed     Abstract available


  41. XU L, Feng J, Xu X, Li X, et al
    IL-17-producing gammadeltaT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1(+)CD11b(+) myeloid-derived suppressor cells.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01299.
    PubMed     Abstract available


  42. MURATA M, Terakura S, Wake A, Miyao K, et al
    Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence.
    Bone Marrow Transplant. 2021 May 11. pii: 10.1038/s41409-021-01304.
    PubMed     Abstract available


  43. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 10. pii: 10.1038/s41409-021-01315.
    PubMed    


  44. ALBERT MH, Sirin M, Hoenig M, Hauck F, et al
    Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
    Bone Marrow Transplant. 2021 May 9. pii: 10.1038/s41409-021-01323.
    PubMed     Abstract available


  45. DE OLIVEIRA RODRIGUES M, de Almeida Testa LH, Dos Santos ACF, Zanetti LP, et al
    Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 8. pii: 10.1038/s41409-021-01329.
    PubMed     Abstract available


  46. SHIRATORI S, Sugita J, Fuji S, Aoki J, et al
    Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01314.
    PubMed     Abstract available


  47. DERENZINI E, Tabanelli V, Sammassimo S, Mazzara S, et al
    Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01320.
    PubMed    


  48. FRIEDMAN D, Dozor AJ, Milner J, D'Souza M, et al
    Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2021 May 6. pii: 10.1038/s41409-021-01298.
    PubMed     Abstract available


  49. KALOYANNIDIS P, Ayyad A, Bahaliwah Z, Blowi B, et al
    Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01318.
    PubMed    


  50. DE LA PUERTA R, Montoro J, Aznar C, Lorenzo I, et al
    Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01319.
    PubMed     Abstract available


  51. OOSTENBRINK LVE, Pool ES, Jol-van der Zijde CM, Jansen-Hoogendijk AM, et al
    Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 3. pii: 10.1038/s41409-021-01302.
    PubMed     Abstract available


    April 2021
  52. TOYODA K, Yasunaga JI, Choi I, Suehiro Y, et al
    The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01311.
    PubMed    


  53. HARADA K, Kimura SI, Fuji S, Najima Y, et al
    Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01310.
    PubMed     Abstract available


  54. SAITO Y, Urashima M, Takahashi Y, Ogawa A, et al
    Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01303.
    PubMed     Abstract available


  55. BURT RK, Muraro PA, Farge D, Oliveira MC, et al
    New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01277.
    PubMed     Abstract available


  56. RAGON BK
    FLT3-ITDos and FLT3-ITDon'ts: navigating maintenance therapy in FLT3-ITD-positive acute myeloid leukemia following stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01269.
    PubMed    


  57. AMONOO HL, El-Jawahri A, Celano CM, Brown LA, et al
    A positive psychology intervention to promote health outcomes in hematopoietic stem cell transplantation: the PATH proof-of-concept trial.
    Bone Marrow Transplant. 2021 Apr 20. pii: 10.1038/s41409-021-01296.
    PubMed     Abstract available


  58. INOUE Y, Okinaka K, Fuji S, Inamoto Y, et al
    Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01291.
    PubMed     Abstract available


  59. FIALA MA, King J, Feinberg D, Goldsmith SR, et al
    Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01295.
    PubMed    


  60. RUSSO D, Polverelli N, Malagola M, Farina M, et al
    Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01287.
    PubMed     Abstract available


  61. EYRE TA, Caillard S, Finel H, Boumendil A, et al
    Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2021 Apr 16. pii: 10.1038/s41409-021-01270.
    PubMed     Abstract available


  62. RAMDIAL JL, Mehta RS, Saliba RM, Alousi AM, et al
    Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01274.
    PubMed     Abstract available


  63. WU J, Fu HX, He Y, Mo XD, et al
    Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01293.
    PubMed     Abstract available


  64. EGLSEER D, Bauer S, Huber-Krassnitzer B, Greinix H, et al
    Malnutrition risk prior to hematopoietic stem cell transplantation predicts mortality in adults.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01292.
    PubMed     Abstract available


  65. NELSON AM, Johnson PC, Kavanaugh AR, Jackson VA, et al
    Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01281.
    PubMed     Abstract available


  66. BADAR T, Szabo A, Litzow M, Burkart M, et al
    Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01279.
    PubMed     Abstract available


  67. LIU W, Fan Z, Zhang Y, Huang F, et al
    Metagenomic next-generation sequencing for identifying pathogens in central nervous system complications after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01243.
    PubMed     Abstract available


  68. HAGHIRI S, Fayech C, Mansouri I, Dufour C, et al
    Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01258.
    PubMed     Abstract available


  69. STATHOPOULOS P, Leger K, Foege M, Lutterotti A, et al
    Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01276.
    PubMed    


    March 2021
  70. DAHER-REYES G, Kim T, Novitzky-Basso I, Kim KH, et al
    Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01255.
    PubMed     Abstract available


  71. BENTO L, Gutierrez A, Novelli S, Montoro J, et al
    Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01264.
    PubMed     Abstract available


  72. LAZZARO C, Castagna L, Lanza F, Laszlo D, et al
    Chemotherapy-based versus chemotherapy-free stem cell mobilization (+/- plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis.
    Bone Marrow Transplant. 2021 Mar 22. pii: 10.1038/s41409-021-01251.
    PubMed     Abstract available


  73. IMOTO H, Yoshioka S, Hiramoto N, Morita-Fujita M, et al
    Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.
    Bone Marrow Transplant. 2021 Mar 10. pii: 10.1038/s41409-021-01263.
    PubMed    


  74. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01254.
    PubMed     Abstract available


  75. KONISHI T, Kusakabe S, Hino A, Inamoto K, et al
    Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01249.
    PubMed    


  76. KAPOOR J, Khushoo V, Garg A, Naim F, et al
    An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01256.
    PubMed    


  77. SHAH RM
    Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01246.
    PubMed     Abstract available


  78. RUGGERI A, Labopin M, Angelucci E, Blaise D, et al
    Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01248.
    PubMed     Abstract available


  79. RITACCO C, Ehx G, Gregoire C, Daulne C, et al
    High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 4. pii: 10.1038/s41409-021-01221.
    PubMed     Abstract available


  80. REUSING SB, Manser AR, Groeneveld-Krentz S, Rebmann V, et al
    HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01231.
    PubMed    


  81. ELMARIAH H, Naqvi SMH, Kim J, Nishihori T, et al
    Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01219.
    PubMed     Abstract available


  82. SHIMOMURA Y, Hara M, Yamamoto H, Uchida N, et al
    Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01217.
    PubMed     Abstract available


  83. PULIAFITO B, Zhao Y, Afshar S, Galitzeck Z, et al
    Comparison of post-transplant vaccination among allogeneic and autologous hematopoietic stem cell transplant patients: a single center quality analysis.
    Bone Marrow Transplant. 2021 Mar 1. pii: 10.1038/s41409-021-01240.
    PubMed    


    February 2021
  84. TANG X, Valdez BC, Ma Y, Zhang Q, et al
    Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01238.
    PubMed     Abstract available


  85. MISKIEWICZ-BUJNA J, Miskiewicz-Migon I, Panasiuk A, Kubica-Cielinska A, et al
    Severe and fatal toxicity after hematopoietic stem cell transplantation in GNE defect-associated thrombocytopenia.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01235.
    PubMed    


  86. LAI X, Liu L, Zhang Z, Shi L, et al
    Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Bone Marrow Transplant. 2021 Feb 19. pii: 10.1038/s41409-021-01233.
    PubMed     Abstract available


  87. CHRISTOPEIT M, Reichard M, Niederwieser C, Massoud R, et al
    Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01225.
    PubMed    


  88. SHEIKH MA, Im A, Ballen K, Hashmi SK, et al
    Association of graft-versus-host-disease with neurologic complications: clinical paradigm and future directions.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01216.
    PubMed    


  89. PAUTAS C, Raffoux E, Lambert J, Legrand O, et al
    Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-020-01207.
    PubMed     Abstract available


  90. RUBEN CL, Pirsl F, Steinberg SM, Holtzman NG, et al
    Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-021-01211.
    PubMed     Abstract available


  91. PRINCE HM, Abeyakoon C
    Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sezary syndrome: never-late, never-never?
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-020-01150.
    PubMed    


    January 2021
  92. DAI H, Penack O, Radujkovic A, Schult D, et al
    Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
    Bone Marrow Transplant. 2021 Jan 30. pii: 10.1038/s41409-020-01186.
    PubMed     Abstract available


  93. AHMED N, Li L, Rojas P, Covut F, et al
    Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01223.
    PubMed    


  94. SAKURAI M, Mori T, Kato K, Kanaya M, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01192.
    PubMed    


  95. CESARO S, Tridello G, Knelange NS, Blijlevens N, et al
    Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01212.
    PubMed     Abstract available


  96. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01200.
    PubMed     Abstract available


  97. LOPEZ R, Plat G, Bertrand Y, Ducassou S, et al
    Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study.
    Bone Marrow Transplant. 2021 Jan 16. pii: 10.1038/s41409-020-01180.
    PubMed     Abstract available


  98. VAN LEEUWEN SJM, Proctor GB, Laheij AMGA, Potting CMJ, et al
    Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01185.
    PubMed     Abstract available


  99. WEI N, Wang Y, Wang J, Wu L, et al
    Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01193.
    PubMed    


  100. DOMINGO-DOMENECH E, Duarte RF, Boumedil A, Onida F, et al
    Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sezary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01197.
    PubMed     Abstract available


  101. WALLACE G, Khandelwal P, Myers KC, Perentesis EMR, et al
    Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01189.
    PubMed     Abstract available


  102. OKOEV G, Weisdorf DJ, Wagner JE, Blazar BR, et al
    Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01195.
    PubMed     Abstract available


  103. SUN X, Su Y, Liu X, Zhang Y, et al
    Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models.
    Bone Marrow Transplant. 2021 Jan 7. pii: 10.1038/s41409-020-01187.
    PubMed     Abstract available


    December 2020
  104. GIAMMARCO S, Raiola AM, Di Grazia C, Bregante S, et al
    Second haploidentical stem cell transplantation for primary graft failure.
    Bone Marrow Transplant. 2020 Dec 16. pii: 10.1038/s41409-020-01183.
    PubMed     Abstract available


  105. XU ZL, Huang XJ
    Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01169.
    PubMed     Abstract available


  106. SANZ J, Labopin M, Sanz MA, Aljurf M, et al
    Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01162.
    PubMed     Abstract available


  107. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
    Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
    PubMed     Abstract available


  108. MORI T, Kikuchi T, Koh M, Koda Y, et al
    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
    PubMed     Abstract available


  109. MONTORO J, Chorao P, Bento L, Cabrero M, et al
    Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01161.
    PubMed    


  110. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    PubMed     Abstract available


  111. HIRSCHBUHL K, Labopin M, Houhou M, Gabellier L, et al
    Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2020 Dec 9. pii: 10.1038/s41409-020-01173.
    PubMed     Abstract available


  112. MAZIARZ RT, Levis M, Patnaik MM, Scott BL, et al
    Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
    Bone Marrow Transplant. 2020 Dec 7. pii: 10.1038/s41409-020-01153.
    PubMed     Abstract available


  113. BAKER LX, Chen F, Ssempijja Y, Byrne M, et al
    Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Dec 5. pii: 10.1038/s41409-020-01158.
    PubMed    


  114. SONG GY, Yoon DH, Suh C, Moon JH, et al
    Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01160.
    PubMed     Abstract available


  115. BAI B, Wang XX, Gao Y, Li PF, et al
    Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01164.
    PubMed     Abstract available


  116. VAXMAN I, Visram A, Kumar S, Dispenzieri A, et al
    Autologous stem cell transplantation for multiple myeloma patients aged >/= 75 treated with novel agents.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01159.
    PubMed     Abstract available


  117. JABBOUR J, Manana B, Zahreddine A, Al-Shaar L, et al
    Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial.
    Bone Marrow Transplant. 2020 Dec 1. pii: 10.1038/s41409-020-01154.
    PubMed     Abstract available


    November 2020
  118. BERRO M, Rivas M, Trucco J, Paganini I, et al
    Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center exper
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01146.
    PubMed    


  119. PAVIGLIANITI A, Labopin M, Blaise D, Socie G, et al
    Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01155.
    PubMed     Abstract available


  120. OTTH M, Schindera C, Gungor T, Ansari M, et al
    Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study.
    Bone Marrow Transplant. 2020 Nov 25. pii: 10.1038/s41409-020-01137.
    PubMed     Abstract available


  121. HUA J, Zhang J, Zhang X, Wu X, et al
    Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 24. pii: 10.1038/s41409-020-01140.
    PubMed     Abstract available


  122. EBBESEN M, Weischendorff S, Kielsen K, Kammersgaard M, et al
    Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01127.
    PubMed     Abstract available


  123. MENGLING T, Rall G, Bernas SN, Astreou N, et al
    Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01138.
    PubMed     Abstract available


  124. JENTZSCH M, Grimm J, Bill M, Brauer D, et al
    ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 19. pii: 10.1038/s41409-020-01129.
    PubMed     Abstract available


  125. VAXMAN I, Sidiqi MH, Al Saleh AS, Kumar S, et al
    Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.
    Bone Marrow Transplant. 2020 Nov 18. pii: 10.1038/s41409-020-01136.
    PubMed     Abstract available


  126. BLAGOV S, Zvyagin IV, Shelikhova L, Khismatullina R, et al
    T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after alphabeta T cell-depleted hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01128.
    PubMed     Abstract available


  127. MAAS-BAUER K, Kiote-Schmidt C, Bertz H, Apostolova P, et al
    Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01122.
    PubMed     Abstract available


  128. KANG HM, Kim SK, Lee JW, Chung NG, et al
    Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01121.
    PubMed     Abstract available


  129. CASTAGNA L, Pagliardini T, Bramanti S, Schiano de Colella JM, et al
    Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
    Bone Marrow Transplant. 2020 Nov 15. pii: 10.1038/s41409-020-01133.
    PubMed     Abstract available


  130. MARCO-AYALA J, Gomez-Segui I, Sanz G, Solves P, et al
    Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
    Bone Marrow Transplant. 2020 Nov 14. pii: 10.1038/s41409-020-01124.
    PubMed     Abstract available


  131. KHAN M, Iftikhar R, Ghafoor T, Hussain F, et al
    Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan.
    Bone Marrow Transplant. 2020 Nov 12. pii: 10.1038/s41409-020-01126.
    PubMed     Abstract available


  132. GERTZ MA, Lacy MQ, Jacob EK, Hogan WJ, et al
    Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2020 Nov 11. pii: 10.1038/s41409-020-01131.
    PubMed    


  133. SULTAN AM, Mahmoud HK, Fathy GM, Abdelfattah NM, et al
    The outcome of hematopoietic stem cell transplantation patients with COVID-19 infection.
    Bone Marrow Transplant. 2020 Nov 4. pii: 10.1038/s41409-020-01094.
    PubMed    


  134. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress.
    Bone Marrow Transplant. 2020 Nov 3. pii: 10.1038/s41409-020-01098.
    PubMed     Abstract available


  135. MORITA K, Fujiwara SI, Ikeda T, Kawaguchi SI, et al
    Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01096.
    PubMed     Abstract available


    October 2020
  136. IWAMOTO M, Ikegawa S, Kondo T, Meguri Y, et al
    Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01100.
    PubMed    


  137. YOON JH, Min GJ, Park SS, Park S, et al
    Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01097.
    PubMed     Abstract available


  138. IRENE GC, Albert E, Anna BV, Rahinatu A, et al
    Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching.
    Bone Marrow Transplant. 2020 Oct 26. pii: 10.1038/s41409-020-01092.
    PubMed     Abstract available


  139. EL-SERAFI A, He R, Zheng W, Benkossou F, et al
    Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.
    Bone Marrow Transplant. 2020 Oct 21. pii: 10.1038/s41409-020-01091.
    PubMed     Abstract available


  140. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 20. pii: 10.1038/s41409-020-01090.
    PubMed     Abstract available


  141. MODI D, Kim S, Deol A, Ayash L, et al
    Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Oct 16. pii: 10.1038/s41409-020-01079.
    PubMed     Abstract available


  142. BENTO L, Boumendil A, Finel H, Khvedelidze I, et al
    Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01075.
    PubMed     Abstract available


  143. KEKRE N, Kim HT, Hofer J, Ho VT, et al
    Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01083.
    PubMed     Abstract available


  144. MORISHIMA S, Fukuda T, Doki N, Mori T, et al
    Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
    Bone Marrow Transplant. 2020 Oct 9. pii: 10.1038/s41409-020-01070.
    PubMed     Abstract available


  145. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2020 Oct 7. pii: 10.1038/s41409-020-01053.
    PubMed     Abstract available


  146. LOKE J, Labopin M, Craddock C, Niederwieser D, et al
    Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01072.
    PubMed     Abstract available


  147. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01069.
    PubMed     Abstract available


    September 2020
  148. SUGITA J, Kamimura T, Ishikawa T, Ota S, et al
    Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Sep 24. pii: 10.1038/s41409-020-01065.
    PubMed     Abstract available


  149. MAAKARON JE, McKenna D Jr, El-Jurdi N, Arora M, et al
    COVID19 seroconversion in an unrelated stem cell donor.
    Bone Marrow Transplant. 2020 Sep 22. pii: 10.1038/s41409-020-01066.
    PubMed    


  150. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01056.
    PubMed     Abstract available


  151. SALEH W, Katz J
    Periodontal diseases, caries, and dental abscesses prevalence in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01057.
    PubMed    


  152. ZAMPERLINI-NETTO G, Fernandes JF, Garcia JL, Ribeiro AAF, et al
    COVID-19 after hematopoietic stem cell transplantation: report of two children.
    Bone Marrow Transplant. 2020 Sep 16. pii: 10.1038/s41409-020-01041.
    PubMed    


  153. KEKRE N, Kim HT, Hofer J, Ho VT, et al
    Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Sep 8. pii: 10.1038/s41409-020-01049.
    PubMed     Abstract available


  154. JIANG S, Fan Y, Fang Y, Hou C, et al
    The role of EVI1 gene quantification in AML patients with 11q23/MLL rearrangement after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Sep 5. pii: 10.1038/s41409-020-01048.
    PubMed     Abstract available


  155. MEJDAHL NIELSEN M, Mathiesen S, Suominen A, Sorensen K, et al
    Altered body composition in male long-term survivors of paediatric allogeneic haematopoietic stem cell transplantation: impact of conditioning regimen, chronic graft-versus-host disease and hypogonadism.
    Bone Marrow Transplant. 2020 Sep 2. pii: 10.1038/s41409-020-01038.
    PubMed     Abstract available


  156. SHIMONI A, Shem-Tov N, Yerushalmi R, Danylesko I, et al
    Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors.
    Bone Marrow Transplant. 2020 Sep 2. pii: 10.1038/s41409-020-01044.
    PubMed     Abstract available


  157. XU X, Yang J, Cai Y, Li S, et al
    Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem
    Bone Marrow Transplant. 2020 Sep 1. pii: 10.1038/s41409-020-01047.
    PubMed    


    August 2020
  158. POLITIKOS I, Mazis CM, Naputo KA, Skinner K, et al
    Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units.
    Bone Marrow Transplant. 2020 Aug 29. pii: 10.1038/s41409-020-01042.
    PubMed    


  159. EVEN-OR E, NaserEddin A, Dinur Schejter Y, Shadur B, et al
    Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases.
    Bone Marrow Transplant. 2020 Aug 27. pii: 10.1038/s41409-020-01040.
    PubMed     Abstract available


  160. PETER K, Siska PJ, Roider T, Matos C, et al
    1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 27. pii: 10.1038/s41409-020-01031.
    PubMed     Abstract available


  161. SAHIN U, Soydan E, Gokmen A, Ozcan M, et al
    Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 26. pii: 10.1038/s41409-020-01043.
    PubMed    


  162. LU X, Tang LV, Wang HF, You Y, et al
    The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19.
    Bone Marrow Transplant. 2020 Aug 25. pii: 10.1038/s41409-020-01035.
    PubMed    


  163. ROH YY, Hahn SM, Kim HS, Ahn WK, et al
    Efficacy of low dose and short duration defibrotide prophylaxis for hepatic veno-occlusive disease after autologous haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 24. pii: 10.1038/s41409-020-01036.
    PubMed     Abstract available


  164. HARADA K, Fuji S, Seo S, Uchida N, et al
    Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 20. pii: 10.1038/s41409-020-00999.
    PubMed     Abstract available


  165. PREM S, Remberger M, Salas MQ, Al-Shaibani Z, et al
    Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies.
    Bone Marrow Transplant. 2020 Aug 14. pii: 10.1038/s41409-020-01030.
    PubMed    


  166. LAURENT V, Fronteau C, Antier C, Dupuis P, et al
    Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience.
    Bone Marrow Transplant. 2020 Aug 14. pii: 10.1038/s41409-020-01033.
    PubMed     Abstract available


  167. LEMIEUX C, Muffly LS, Rezvani A, Lowsky R, et al
    Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma.
    Bone Marrow Transplant. 2020 Aug 11. pii: 10.1038/s41409-020-01026.
    PubMed     Abstract available


  168. FUJIMOTO A, Ishida F, Izutsu K, Yamasaki S, et al
    Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia.
    Bone Marrow Transplant. 2020 Aug 10. pii: 10.1038/s41409-020-01009.
    PubMed     Abstract available


  169. SHIBAMIYA A, Ohwada C, Ishii A, Mishina T, et al
    Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome.
    Bone Marrow Transplant. 2020 Aug 10. pii: 10.1038/s41409-020-01024.
    PubMed    


  170. MCCAUGHAN G, Ma D, Moore J
    Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01025.
    PubMed    


  171. EL-HARASIS MA, Hefazi M, Julakanti R, Hogan WJ, et al
    Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01021.
    PubMed    


  172. STAMOULI M, Tsonis I, Gkirkas K, Economopoulou C, et al
    Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01022.
    PubMed    


  173. SHI J, Cao L, Luo Y, Zhao Y, et al
    Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 4. pii: 10.1038/s41409-020-01015.
    PubMed    


    July 2020
  174. WOLFF D, Herzberg PY, Herrmann A, Pavletic SZ, et al
    Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.
    Bone Marrow Transplant. 2020 Jul 31. pii: 10.1038/s41409-020-01017.
    PubMed     Abstract available


  175. GAGELMANN N, Eikema DJ, de Wreede LC, Rambaldi A, et al
    Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT.
    Bone Marrow Transplant. 2020 Jul 24. pii: 10.1038/s41409-020-01007.
    PubMed     Abstract available


  176. JEPPESEN H, Sengelov H, Eriksson F, Kiilgaard JF, et al
    Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark - factors associated with risks and rates in adults according to conditioning regimen.
    Bone Marrow Transplant. 2020 Jul 12. pii: 10.1038/s41409-020-0993.
    PubMed     Abstract available


  177. DEBUREAUX PE, Sicre de Fontbrune F, Bonfim C, Dalle JH, et al
    FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study.
    Bone Marrow Transplant. 2020 Jul 10. pii: 10.1038/s41409-020-0994.
    PubMed    


  178. MEDVEDOVA E, Strasfeld L, Stenzel P, Maziarz RT, et al
    Autopsy among recipients of stem cell transplant for hematologic malignancies in the modern era.
    Bone Marrow Transplant. 2020 Jul 8. pii: 10.1038/s41409-020-0992.
    PubMed    


  179. MAUNG KK, Chen BJ, Barak I, Li Z, et al
    Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jul 5. pii: 10.1038/s41409-020-0991.
    PubMed     Abstract available


  180. SHIRATORI S, Sugita J, Ota S, Kasahara S, et al
    Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Jul 5. pii: 10.1038/s41409-020-0985.
    PubMed     Abstract available


  181. AGRAWAL V, Ranganath P, Ervin KD, Schmidt CA, et al
    Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome.
    Bone Marrow Transplant. 2020 Jul 4. pii: 10.1038/s41409-020-0987.
    PubMed     Abstract available


  182. AL SALEH AS, Parmar HV, Vaxman I, Visram A, et al
    Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Jul 4. pii: 10.1038/s41409-020-0990.
    PubMed    


  183. BURT RK, Han X, Quigley K, Arnautovic I, et al
    Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days.
    Bone Marrow Transplant. 2020 Jul 1. pii: 10.1038/s41409-020-0978.
    PubMed     Abstract available


    June 2020
  184. FRIETSCH JJ, Hunstig F, Wittke C, Junghanss C, et al
    Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity.
    Bone Marrow Transplant. 2020 Jun 30. pii: 10.1038/s41409-020-0984.
    PubMed     Abstract available


  185. PAGLIUCA S, Prata PH, Xhaard A, Frieri C, et al
    Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jun 25. pii: 10.1038/s41409-020-0977.
    PubMed     Abstract available


  186. GU B, Shi BY, Zhang X, Zhou SY, et al
    Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells.
    Bone Marrow Transplant. 2020 Jun 24. pii: 10.1038/s41409-020-0982.
    PubMed     Abstract available


  187. IKEGAME K, Kaida K, Fukunaga K, Osugi Y, et al
    Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.
    Bone Marrow Transplant. 2020 Jun 20. pii: 10.1038/s41409-020-0980.
    PubMed     Abstract available


  188. SANTOSA D, Pangarsa EA, Setiawan B, Naibaho RM, et al
    Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia.
    Bone Marrow Transplant. 2020 Jun 17. pii: 10.1038/s41409-020-0973.
    PubMed    


  189. MERLI M, Luminari S, Farina L, Cocito F, et al
    Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
    Bone Marrow Transplant. 2020 Jun 15. pii: 10.1038/s41409-020-0967.
    PubMed    


  190. NIU A, McDougal A, Ning B, Safa F, et al
    COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma.
    Bone Marrow Transplant. 2020 Jun 15. pii: 10.1038/s41409-020-0972.
    PubMed    


  191. YANG L, Tan Y, Shi J, Zhao Y, et al
    Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
    Bone Marrow Transplant. 2020 Jun 15. pii: 10.1038/s41409-020-0962.
    PubMed     Abstract available


  192. ANURATHAPAN U, Apiwattanakul N, Pakakasama S, Pongphitcha P, et al
    Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.
    Bone Marrow Transplant. 2020 Jun 11. pii: 10.1038/s41409-020-0969.
    PubMed    


  193. ABDALLAH N, Sidana S, Dispenzieri A, Lacy M, et al
    Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis.
    Bone Marrow Transplant. 2020 Jun 9. pii: 10.1038/s41409-020-0964.
    PubMed     Abstract available


  194. BUCHTELE N, Rabitsch W, Knaus HA, Wohlfarth P, et al
    Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.
    Bone Marrow Transplant. 2020 Jun 1. pii: 10.1038/s41409-020-0958.
    PubMed    


    May 2020
  195. BURT RK, Craig R, Yun L, Halverson A, et al
    A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease.
    Bone Marrow Transplant. 2020 May 28. pii: 10.1038/s41409-020-0953.
    PubMed    


  196. LI L, Kolk M, Fernandez-Vina M, de Lima M, et al
    Interrogating the impact of KIR ligand mismatch in engraftment following HLA-disparate stem cell transplantation.
    Bone Marrow Transplant. 2020 May 27. pii: 10.1038/s41409-020-0957.
    PubMed     Abstract available


  197. PURTILL D, Cirillo M, Fogarty J, Tan D, et al
    Early cessation of a randomised study in acute graft versus host disease: upfront mesenchymal stromal cells with corticosteroids versus corticosteroids alone.
    Bone Marrow Transplant. 2020 May 27. pii: 10.1038/s41409-020-0955.
    PubMed    


  198. HUNTLEY D, Gimenez E, Pascual MJ, Vazquez L, et al
    Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0950.
    PubMed    


  199. MODEMANN F, Ayuk F, Wolschke C, Christopeit M, et al
    Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0952.
    PubMed     Abstract available


  200. VAN DE WYNGAERT Z, Nerich V, Fouquet G, Chretien ML, et al
    Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0940.
    PubMed     Abstract available


  201. YOSHIDA N, Takahashi Y, Yabe H, Kobayashi R, et al
    Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0948.
    PubMed     Abstract available


  202. SELLNER L, Schetelig J, Koster L, Choi G, et al
    Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.
    Bone Marrow Transplant. 2020 May 22. pii: 10.1038/s41409-020-0946.
    PubMed    


  203. NACHEVA E, Ahyee T, Addada J, Navarette C, et al
    Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening.
    Bone Marrow Transplant. 2020 May 21. pii: 10.1038/s41409-020-0945.
    PubMed     Abstract available


  204. LEVY-BARAZANY H, Shachnai-Pinkas L, Rodionov G, Saar A, et al
    Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance.
    Bone Marrow Transplant. 2020 May 20. pii: 10.1038/s41409-020-0941.
    PubMed     Abstract available


  205. LEV-SAGIE A, Adar-Walling E, Gumer A, Grisariu S, et al
    Management and long-term consequences of genital graft versus host disease following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 May 15. pii: 10.1038/s41409-020-0933.
    PubMed     Abstract available


  206. SUREDA A, Genadieva Stavrik S, Boumendil A, Finel H, et al
    Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2020 May 15. pii: 10.1038/s41409-020-0929.
    PubMed     Abstract available


  207. MOTAEI J, Yaghmaie M, Pashaiefar H, Mousavi SA, et al
    Differential microRNAs expression in acute graft-versus-host disease as potential diagnostic biomarkers.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0949.
    PubMed    


  208. DAMLAJ M, Abuelgasim KA, Alhejazi A, Alahmari B, et al
    Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0935.
    PubMed    


  209. POLVERELLI N, Tura P, Battipaglia G, Malagola M, et al
    Multidimensional geriatric assessment for elderly hematological patients (>/=60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients.
    Bone Marrow Transplant. 2020 May 12. pii: 10.1038/s41409-020-0934.
    PubMed     Abstract available


  210. ROBESOVA B, Drncova M, Folta A, Krejci M, et al
    Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR.
    Bone Marrow Transplant. 2020 May 9. pii: 10.1038/s41409-020-0938.
    PubMed    


  211. CHANG YJ, Xu LP, Wang Y, Zhang XH, et al
    Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody.
    Bone Marrow Transplant. 2020 May 8. pii: 10.1038/s41409-020-0928.
    PubMed     Abstract available


  212. FANTOZZI PJ, Treister NS, Cutler CS, Villa A, et al
    Oral health in allogeneic hematopoietic stem cells transplantation survivors.
    Bone Marrow Transplant. 2020 May 7. pii: 10.1038/s41409-020-0927.
    PubMed    


  213. REES MJ, Spencer A, Browett P, Alvaro F, et al
    High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission.
    Bone Marrow Transplant. 2020 May 6. pii: 10.1038/s41409-020-0924.
    PubMed    


  214. COOPERRIDER JH, Fulton N, Artz AS, Larson RA, et al
    Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
    Bone Marrow Transplant. 2020 May 6. pii: 10.1038/s41409-020-0925.
    PubMed    


  215. GERGIS U, Reich-Slotky R, Abdulahad B
    Gastric bypass bariatric surgery in patients undergoing allogeneic hematopoietic stem cell transplantation warrants special considerations.
    Bone Marrow Transplant. 2020 May 5. pii: 10.1038/s41409-020-0922.
    PubMed    


  216. MONTORO J, Pinana JL, Hernandez-Boluda JC, Hernani R, et al
    Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors.
    Bone Marrow Transplant. 2020 May 5. pii: 10.1038/s41409-020-0921.
    PubMed     Abstract available


  217. SAHU KK, Siddiqui AD, Cerny J
    COVID-19 pandemic and impact on hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 May 4. pii: 10.1038/s41409-020-0913.
    PubMed    


  218. BUHLER S, Baldomero H, Ferrari-Lacraz S, Nunes JM, et al
    Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 May 4. pii: 10.1038/s41409-020-0862.
    PubMed     Abstract available


  219. PERIC Z, Labopin M, Peczynski C, Polge E, et al
    Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT.
    Bone Marrow Transplant. 2020 May 2. pii: 10.1038/s41409-020-0878.
    PubMed     Abstract available


  220. AL SALEH AS, Sidiqi MH, Lee J, Dispenzieri A, et al
    Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant.
    Bone Marrow Transplant. 2020 May 1. pii: 10.1038/s41409-020-0916.
    PubMed     Abstract available


  221. OLRY DE LABRY LIMA A, Matas Hoces A, Gimeno Ballester V, Rios Sanchez E, et al
    Cost-effectiveness of lenalidomide.
    Bone Marrow Transplant. 2020;55:853-854.
    PubMed    


  222. DHANASIRI S
    Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells.
    Bone Marrow Transplant. 2020;55:987-988.
    PubMed    


    April 2020
  223. NOVAK P, Klyuchnikov E, von Pein UM, Gullstorf M, et al
    Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+ selected donor cells without immunosuppression.
    Bone Marrow Transplant. 2020 Apr 29. pii: 10.1038/s41409-020-0912.
    PubMed    


  224. ELGOHARY G, El Fakih R, de Latour R, Risitano A, et al
    Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAW
    Bone Marrow Transplant. 2020 Apr 28. pii: 10.1038/s41409-020-0897.
    PubMed     Abstract available


  225. DI RENZO N, Musso M, Scime R, Cupri A, et al
    Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantat
    Bone Marrow Transplant. 2020 Apr 28. pii: 10.1038/s41409-020-0909.
    PubMed     Abstract available


  226. CAI X, Fu HX, Mo XD, Wang Y, et al
    Comparison of hemorrhagic and ischemic stroke after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Apr 24. pii: 10.1038/s41409-020-0903.
    PubMed     Abstract available


  227. LEIPER A, Houwing M, Davies EG, Rao K, et al
    Correction: Anti-Mullerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens.
    Bone Marrow Transplant. 2020 Apr 24. pii: 10.1038/s41409-020-0914.
    PubMed     Abstract available


  228. LAURENT C, Marjanovic Z, Ricard L, Henes J, et al
    Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blo
    Bone Marrow Transplant. 2020 Apr 22. pii: 10.1038/s41409-020-0907.
    PubMed     Abstract available


  229. CHEN Q, Zhao X, Fu HX, Chen YH, et al
    Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes.
    Bone Marrow Transplant. 2020 Apr 18. pii: 10.1038/s41409-020-0894.
    PubMed     Abstract available


  230. JO JC, Kim JS, Lee JH, Lee JH, et al
    Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL).
    Bone Marrow Transplant. 2020 Apr 17. pii: 10.1038/s41409-020-0908.
    PubMed    


  231. AL-MOFAREH M, Ayas M, Al-Seraihy A, Siddiqui K, et al
    Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0885.
    PubMed     Abstract available


  232. MERLI P, Vacca P, Galaverna F, Tumino N, et al
    TCRalphabeta/CD19 depleted hematopoietic stem cell transplantation from haploidentical donors: dissecting the GvL/GvHD conundrum.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0891.
    PubMed    


  233. CARAPITO R, Aouadi I, Pichot A, Spinnhirny P, et al
    Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0886.
    PubMed     Abstract available


  234. FANTOZZI PJ, Villa A, Antin JH, Treister N, et al
    Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0889.
    PubMed    


  235. CESARO S, Pillon M, Sauer M, Smiers F, et al
    Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Bloo
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0901.
    PubMed     Abstract available


  236. KHANDELWAL P, Fukuda T, Teusink-Cross A, Kashuba ADM, et al
    CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0888.
    PubMed     Abstract available


  237. UZIEL O, Lahav M, Shargian L, Beery E, et al
    Correction: Premature ageing following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Apr 8. pii: 10.1038/s41409-020-0900.
    PubMed     Abstract available


    March 2020
  238. LEIPER A, Houwing M, Davies EG, Rao K, et al
    Anti-Mullerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens.
    Bone Marrow Transplant. 2020 Mar 30. pii: 10.1038/s41409-020-0866.
    PubMed     Abstract available


  239. EHMANN MA, Medinger M, Bodenmann B, Kraft S, et al
    Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host dis
    Bone Marrow Transplant. 2020 Mar 30. pii: 10.1038/s41409-020-0880.
    PubMed    


  240. LIU L, Zhang Y, Jiao W, Zhou H, et al
    Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases.
    Bone Marrow Transplant. 2020 Mar 26. pii: 10.1038/s41409-020-0874.
    PubMed     Abstract available


  241. JEKER B, Farag S, Taleghani BM, Novak U, et al
    A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients.
    Bone Marrow Transplant. 2020 Mar 25. pii: 10.1038/s41409-020-0875.
    PubMed    


  242. HUNTLEY D, Gimenez E, Pascual MJ, Remigia MJ, et al
    Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 Mar 23. pii: 10.1038/s41409-020-0865.
    PubMed     Abstract available


  243. SZER J, Weisdorf D, Querol S, Foeken L, et al
    The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.
    Bone Marrow Transplant. 2020 Mar 23. pii: 10.1038/s41409-020-0873.
    PubMed    


  244. KALWAK K, Mielcarek M, Patrick K, Styczynski J, et al
    Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies.
    Bone Marrow Transplant. 2020 Mar 20. pii: 10.1038/s41409-020-0869.
    PubMed     Abstract available


  245. SUZUKI T, Kawada JI, Nishikawa E, Torii Y, et al
    Association between graft source and response to live-attenuated vaccination in pediatric hematopoietic stem cell transplantation recipients: a single-center retrospective study.
    Bone Marrow Transplant. 2020 Mar 20. pii: 10.1038/s41409-020-0867.
    PubMed    


  246. ROVIRA M, Villamor N, Cobo F, Fernandez-Aviles F, et al
    Is chronic lymphocytic leukemia curable? A clinical case relapsing 21 years after allogeneic stem-cell transplantation.
    Bone Marrow Transplant. 2020 Mar 20. pii: 10.1038/s41409-020-0861.
    PubMed    


  247. CESARO S, Pillon M, Sauer M, Smiers F, et al
    Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow
    Bone Marrow Transplant. 2020 Mar 19. pii: 10.1038/s41409-020-0863.
    PubMed     Abstract available


  248. TANG X, Zhang Y, Jing Y, Lu W, et al
    Allogeneic hematopoietic stem cell transplantation using unrelated cord blood or unmanipulated haploidentical donors is effective in pediatric chronic granulomatous disease with inflammatory complications and severe infection.
    Bone Marrow Transplant. 2020 Mar 17. pii: 10.1038/s41409-020-0864.
    PubMed    


  249. BRISSOT E, Labopin M, Russo D, Martin S, et al
    Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2020 Mar 17. pii: 10.1038/s41409-020-0849.
    PubMed     Abstract available


  250. PICHEREAU C, Lengline E, Valade S, Michonneau D, et al
    Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score.
    Bone Marrow Transplant. 2020 Mar 17. pii: 10.1038/s41409-020-0857.
    PubMed     Abstract available


  251. BACIGALUPO A, Angelucci E, Raiola AM, Varaldo R, et al
    Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab.
    Bone Marrow Transplant. 2020 Mar 13. pii: 10.1038/s41409-020-0855.
    PubMed     Abstract available


  252. YAMASHITA T, Takami A, Uchida N, Fukuda T, et al
    Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan.
    Bone Marrow Transplant. 2020 Mar 12. pii: 10.1038/s41409-020-0856.
    PubMed     Abstract available


  253. KANDA J, Umeda K, Kato K, Murata M, et al
    Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.
    Bone Marrow Transplant. 2020 Mar 11. pii: 10.1038/s41409-020-0853.
    PubMed     Abstract available


  254. ANAGNOSTOU T, Sakemura R, Forsman CL, Patnaik MS, et al
    Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes.
    Bone Marrow Transplant. 2020 Mar 11. pii: 10.1038/s41409-020-0851.
    PubMed    


  255. GLUCKMAN E, Fuente J, Cappelli B, Scigliuolo GM, et al
    The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Bone Marrow Transplant. 2020 Mar 10. pii: 10.1038/s41409-020-0847.
    PubMed     Abstract available


  256. PATEL SS, Lapin B, Majhail NS, Hamilton BK, et al
    Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpoints.
    Bone Marrow Transplant. 2020 Mar 10. pii: 10.1038/s41409-020-0850.
    PubMed     Abstract available


  257. BASTOS-OREIRO M, Balsalobre P, Miralles P, Berenguer J, et al
    Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma.
    Bone Marrow Transplant. 2020 Mar 4. pii: 10.1038/s41409-020-0846.
    PubMed     Abstract available


  258. MORLAND B, Kepak T, Dallorso S, Sevilla J, et al
    Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC).
    Bone Marrow Transplant. 2020 Mar 3. pii: 10.1038/s41409-020-0836.
    PubMed     Abstract available


  259. BLAISE D, Calvin S, Cuvelier S, Ben Soussan P, et al
    REBOUND "Trained to live again": The practice of great Olympic coaches improves and enhances the quality of life of cancer patients in remission after hematopoietic stem cell allogeneic transplantation.
    Bone Marrow Transplant. 2020 Mar 2. pii: 10.1038/s41409-020-0845.
    PubMed    


  260. HONG Y, Liu L, Chang Y, Wang Y, et al
    CD8(+)CD161(hi) T cells are associated with acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Mar 2. pii: 10.1038/s41409-020-0842.
    PubMed    


    February 2020
  261. UZIEL O, Lahav M, Shragian L, Beery E, et al
    Premature ageing following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 24. pii: 10.1038/s41409-020-0839.
    PubMed     Abstract available


  262. CUESTA-MATEOS C, Portero-Sainz I, Garcia-Peydro M, Alcain J, et al
    Evaluation of therapeutic targeting of CCR7 in acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Feb 21. pii: 10.1038/s41409-020-0830.
    PubMed     Abstract available


  263. NAVA T, Ansari M, Dalle JH, de Heredia CD, et al
    Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Tr
    Bone Marrow Transplant. 2020 Feb 20. pii: 10.1038/s41409-020-0838.
    PubMed     Abstract available


  264. MOISEEV IS, Morozova EV, Bykova TA, Paina OV, et al
    Long-term outcomes of ruxolitinib therapy in steroid-refractory graft-versus-host disease in children and adults.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0834.
    PubMed     Abstract available


  265. SWARTLING L, Norden R, Samuelsson E, Boriskina K, et al
    Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0823.
    PubMed     Abstract available


  266. NISHIKAWA K, Kimura K, Kanda Y, Sugiyama M, et al
    A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0833.
    PubMed     Abstract available


  267. ACHINI FR, Smiers F, Jan Zwaginga J, van Tol MJD, et al
    Plasmapheresis to eliminate immunosuppressive alemtuzumab levels in a child with disseminated adenovirus infection after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0837.
    PubMed    


  268. SHOUVAL R, Teper O, Fein JA, Danylesko I, et al
    LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell.
    Bone Marrow Transplant. 2020 Feb 17. pii: 10.1038/s41409-020-0829.
    PubMed     Abstract available


  269. RU Y, Zhang X, Song T, Ding Y, et al
    Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes.
    Bone Marrow Transplant. 2020 Feb 17. pii: 10.1038/s41409-020-0831.
    PubMed     Abstract available


  270. SZER J
    Is there no place like home for an allogeneic stem cell transplant?
    Bone Marrow Transplant. 2020 Feb 14. pii: 10.1038/s41409-020-0828.
    PubMed    


  271. YOO JW, Im HJ, Kim H, Koh KN, et al
    Improved outcomes of allogeneic hematopoietic stem cell transplantation including haploidentical transplantation for childhood myelodysplastic syndrome.
    Bone Marrow Transplant. 2020 Feb 13. pii: 10.1038/s41409-020-0814.
    PubMed     Abstract available


  272. GRONVOLD B, Ali MM, Remberger M, Mattsson J, et al
    HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 13. pii: 10.1038/s41409-020-0827.
    PubMed    


  273. HARADA K, Fuji S, Seo S, Kanda J, et al
    Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 12. pii: 10.1038/s41409-020-0821.
    PubMed     Abstract available


  274. KAITO S, Najima Y, Harada K, Fukuda T, et al
    Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype.
    Bone Marrow Transplant. 2020 Feb 10. pii: 10.1038/s41409-020-0816.
    PubMed     Abstract available


  275. YOKOYAMA Y, Maie K, Fukuda T, Uchida N, et al
    A high CD34(+) cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors.
    Bone Marrow Transplant. 2020 Feb 10. pii: 10.1038/s41409-020-0817.
    PubMed     Abstract available


  276. STEVEN P, Faust C, Holtick U, Scheid C, et al
    Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 10. pii: 10.1038/s41409-020-0824.
    PubMed    


  277. NAVA T, Ansari M, Dalle JH, de Heredia CD, et al
    Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantatio
    Bone Marrow Transplant. 2020 Feb 6. pii: 10.1038/s41409-020-0818.
    PubMed     Abstract available


  278. ALI N, Cooper B, Tomlinson B, Metheny L, et al
    Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration.
    Bone Marrow Transplant. 2020 Feb 5. pii: 10.1038/s41409-020-0812.
    PubMed    


  279. ALDAWSARI G, Elhaddad A, El Fakih R, Ben Othman T, et al
    Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT).
    Bone Marrow Transplant. 2020 Feb 5. pii: 10.1038/s41409-020-0809.
    PubMed     Abstract available


  280. ZHANG P, Liu B
    Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis.
    Bone Marrow Transplant. 2020 Feb 4. pii: 10.1038/s41409-020-0810.
    PubMed     Abstract available


    January 2020
  281. WETHMAR K, Matern S, Esseling E, Angenendt L, et al
    Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.
    Bone Marrow Transplant. 2020 Jan 30. pii: 10.1038/s41409-020-0801.
    PubMed     Abstract available


  282. SAGLIO F, Zecca M, Pagliara D, Giorgiani G, et al
    Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retro
    Bone Marrow Transplant. 2020 Jan 29. pii: 10.1038/s41409-020-0806.
    PubMed     Abstract available


  283. YAN CH, Wang Y, Mo XD, Sun YQ, et al
    Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jan 28. pii: 10.1038/s41409-020-0790.
    PubMed     Abstract available


  284. KAKINOKI Y, Ishio T, Kimura H, Shimono J, et al
    Successful salvage treatment with antithymocyte globulin for patients with early-onset hemophagocytic lymphohistiocytosis refractory to steroid and etoposide therapy following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jan 28. pii: 10.1038/s41409-020-0802.
    PubMed    


  285. DI GIUSEPPE G, Thacker N, Schechter T, Pole JD, et al
    Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoietic stem cell transplantation: a systematic review.
    Bone Marrow Transplant. 2020 Jan 24. pii: 10.1038/s41409-020-0782.
    PubMed     Abstract available


  286. BONIFAZI F, Rubio MT, Bacigalupo A, Boelens JJ, et al
    Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.
    Bone Marrow Transplant. 2020 Jan 22. pii: 10.1038/s41409-020-0792.
    PubMed     Abstract available


  287. AL-HASHMI H, Alsagheir A, Estanislao A, Bacal J, et al
    Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration.
    Bone Marrow Transplant. 2020 Jan 21. pii: 10.1038/s41409-020-0793.
    PubMed    


  288. DEBUREAUX PE, Febvre de Nailly DL, Tavernier E, Bedoui M, et al
    Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0796.
    PubMed    


  289. OTHMAN J, Armytage T, Wong K, Arthur C, et al
    Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0789.
    PubMed    


  290. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0788.
    PubMed    


  291. HUESO T, Gastinne T, Garciaz S, Tchernonog E, et al
    Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers.
    Bone Marrow Transplant. 2020 Jan 17. pii: 10.1038/s41409-020-0783.
    PubMed     Abstract available


  292. FUJI S, Nagler A, Mohty M, Savani B, et al
    Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy.
    Bone Marrow Transplant. 2020 Jan 13. pii: 10.1038/s41409-020-0784.
    PubMed     Abstract available


  293. MA YR, Wang WJ, Cheng YF, Zhang YY, et al
    Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia.
    Bone Marrow Transplant. 2020 Jan 13. pii: 10.1038/s41409-020-0779.
    PubMed     Abstract available


  294. YIN X, Hu L, Zhang Y, Zhu C, et al
    Correction: PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.
    Bone Marrow Transplant. 2020 Jan 10. pii: 10.1038/s41409-020-0781.
    PubMed     Abstract available


  295. BECK A, Lin R, Reza Rejali A, Rubens M, et al
    Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients.
    Bone Marrow Transplant. 2020 Jan 2. pii: 10.1038/s41409-019-0777.
    PubMed     Abstract available


    December 2019
  296. ALEXANDER T, Samuelson C, Daikeler T, Henes J, et al
    Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry.
    Bone Marrow Transplant. 2019 Dec 17. pii: 10.1038/s41409-019-0763.
    PubMed    


  297. ZHANG H, Hu Y, Wei G, Wu W, et al
    Successful chimeric antigen receptor T cells therapy in extramedullary relapses of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Dec 17. pii: 10.1038/s41409-019-0778.
    PubMed    


  298. RYAN AL, Wadia UD, Jacoby P, Cheung LC, et al
    Immunogenicity of the inactivated influenza vaccine in children who have undergone autologous stem cell transplant.
    Bone Marrow Transplant. 2019 Dec 10. pii: 10.1038/s41409-019-0770.
    PubMed    


  299. JENKYN I, Woodward G, Kelly A, Fowell C, et al
    Oral verruciform xanthoma associated with stem cell transplantation and graft versus host disease in a paediatric patient.
    Bone Marrow Transplant. 2019 Dec 10. pii: 10.1038/s41409-019-0772.
    PubMed    


  300. KATO M, Nakasone H, Nakano N, Fuji S, et al
    Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Dec 9. pii: 10.1038/s41409-019-0765.
    PubMed     Abstract available


  301. YIN X, Hu L, Zhang Y, Zhu C, et al
    PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.
    Bone Marrow Transplant. 2019 Dec 5. pii: 10.1038/s41409-019-0766.
    PubMed     Abstract available


  302. NEWMARCH M, Kostantin E, Tsongalis GJ, Guimond M, et al
    MicroRNAs in graft-versus-host disease: a review of the latest data.
    Bone Marrow Transplant. 2019 Dec 3. pii: 10.1038/s41409-019-0764.
    PubMed     Abstract available


    November 2019
  303. SIDHARTHAN N, Fuchs E, Unni M, Mony U, et al
    HLA-mismatched microtransplantation for relapsed or refractory acute myeloid leukemia as a bridge to allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Nov 29. pii: 10.1038/s41409-019-0761.
    PubMed    


  304. GJAERDE LK, Andersen NS, Friis LS, Kornblit B, et al
    Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Nov 26. pii: 10.1038/s41409-019-0760.
    PubMed    


  305. TOLOMELLI G, Mancuso K, Tacchetti P, Patriarca F, et al
    The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.
    Bone Marrow Transplant. 2019 Nov 25. pii: 10.1038/s41409-019-0756.
    PubMed     Abstract available


  306. SHIROSHITA K, Mori T, Kato J, Sakurai M, et al
    Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention.
    Bone Marrow Transplant. 2019 Nov 21. pii: 10.1038/s41409-019-0755.
    PubMed     Abstract available


  307. SNOWDEN JA, Saccardi R, Orchard K, Ljungman P, et al
    Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and
    Bone Marrow Transplant. 2019 Nov 21. pii: 10.1038/s41409-019-0740.
    PubMed     Abstract available


  308. OGATA M, Uchida N, Fukuda T, Ikegame K, et al
    Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0752.
    PubMed     Abstract available


  309. TAPPENDEN P, Wang Y, Sharrack B, Burman J, et al
    Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Workin
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0747.
    PubMed    


  310. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0745.
    PubMed     Abstract available


  311. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of haploidentical haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0751.
    PubMed    


  312. MAYO SJ, Messner HA, Rourke SB, Howell D, et al
    Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0746.
    PubMed     Abstract available


  313. ABDALLAH N, Kim S, Ayash L, Klimecki S, et al
    Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
    Bone Marrow Transplant. 2019 Nov 18. pii: 10.1038/s41409-019-0744.
    PubMed    


  314. ESCAMILLA GOMEZ V, Garcia-Gutierrez V, Lopez Corral L, Garcia Cadenas I, et al
    Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
    Bone Marrow Transplant. 2019 Nov 7. pii: 10.1038/s41409-019-0731.
    PubMed     Abstract available


  315. MOUKALLED N, Bou Akl I, Al Masri A, Kanafani Z, et al
    Non-irradiated GCSF stimulated leukocyte transfusion for necrotizing fasciitis after allogeneic stem cell transplant: a case report and review of the literature.
    Bone Marrow Transplant. 2019 Nov 7. pii: 10.1038/s41409-019-0743.
    PubMed     Abstract available


  316. DOMINGO-DOMENECH E, Boumendil A, Climent F, Sengeloev H, et al
    Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0734.
    PubMed     Abstract available


  317. DOMINGO-DOMENECH E, Boumendil A, Climent F, Socie G, et al
    Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0732.
    PubMed     Abstract available


  318. SCHULTZE-FLOREY CR, Peczynski C, de Marino I, Polge E, et al
    Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0738.
    PubMed    


  319. BUENO JL, Alegre A, Lopez-Villar O, Querol S, et al
    Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0716.
    PubMed     Abstract available


  320. YOKOYAMA E, Hashimoto D, Hayase E, Ara T, et al
    Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis.
    Bone Marrow Transplant. 2019 Nov 4. pii: 10.1038/s41409-019-0733.
    PubMed     Abstract available


    October 2019
  321. DETEIX C, Mesnil F, Furst S, Milpied N, et al
    Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor.
    Bone Marrow Transplant. 2019 Oct 29. pii: 10.1038/s41409-019-0722.
    PubMed     Abstract available


  322. DU S, He W, Yang Y, Gao X, et al
    Unrelated cord blood transplantation for severe aplastic anemia using intensified immunoablative conditioning regimen leading to high engraftment and survival.
    Bone Marrow Transplant. 2019 Oct 29. pii: 10.1038/s41409-019-0736.
    PubMed    


  323. RYAN AL, Wadia UD, Jacoby P, Cheung LC, et al
    Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.
    Bone Marrow Transplant. 2019 Oct 28. pii: 10.1038/s41409-019-0728.
    PubMed     Abstract available


  324. MORKIS IVC, Vicente BM, Habigzang M, da Silva PO, et al
    Should we evaluate intestinal microbiota of pediatric patients undergoing hematopoietic stem cell transplantation?
    Bone Marrow Transplant. 2019 Oct 28. pii: 10.1038/s41409-019-0727.
    PubMed    


  325. LEICK M, Hunter B, DeFilipp Z, Dey BR, et al
    Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases.
    Bone Marrow Transplant. 2019 Oct 24. pii: 10.1038/s41409-019-0725.
    PubMed     Abstract available


  326. HEINICKE T, Labopin M, Polge E, Niederwieser D, et al
    Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (>/=60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2019 Oct 23. pii: 10.1038/s41409-019-0720.
    PubMed     Abstract available


  327. LIN RJ, Sanchez M, Abbi K, Devlin SM, et al
    Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34(+) selected graft.
    Bone Marrow Transplant. 2019 Oct 23. pii: 10.1038/s41409-019-0723.
    PubMed    


  328. SNOWDEN JA, Saccardi R, Orchard K, Ljungman P, et al
    Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Ac
    Bone Marrow Transplant. 2019 Oct 21. pii: 10.1038/s41409-019-0718.
    PubMed    


  329. HENDRAWAN K, Visweswaran M, Ma DDF, Moore JJ, et al
    Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.
    Bone Marrow Transplant. 2019 Oct 16. pii: 10.1038/s41409-019-0710.
    PubMed     Abstract available


  330. ATOUI A, El Labban M, Ghaoui N, El Darsa H, et al
    Correction: Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2019 Oct 4. pii: 10.1038/s41409-019-0706.
    PubMed     Abstract available


    September 2019
  331. PUERTA-ALCALDE P, Cardozo C, Marco F, Suarez-Lledo M, et al
    Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes.
    Bone Marrow Transplant. 2019 Sep 30. pii: 10.1038/s41409-019-0701.
    PubMed     Abstract available


  332. BAZARBACHI AH, Al Hamed R, Labopin M, Afanasyev B, et al
    Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2019 Sep 27. pii: 10.1038/s41409-019-0702.
    PubMed     Abstract available


  333. STOCKER N, Labopin M, Boussen I, Paccoud O, et al
    Pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes.
    Bone Marrow Transplant. 2019 Sep 27. pii: 10.1038/s41409-019-0699.
    PubMed     Abstract available


  334. SHARRACK B, Saccardi R, Alexander T, Badoglio M, et al
    Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0684.
    PubMed     Abstract available


  335. FELIU J, Potter V, Grimaldi F, Clay J, et al
    Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI).
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0695.
    PubMed     Abstract available


  336. LUFT T, Benner A, Terzer T, Jodele S, et al
    EASIX and mortality after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0703.
    PubMed     Abstract available


  337. YE Y, Ricard L, Stocker N, Mohty M, et al
    A novel mouse model of acute graft-versus-host disease based on chemotherapy conditioning and G-CSF mobilized graft.
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0700.
    PubMed     Abstract available


  338. LI AY, Atenafu EG, Bernard RS, Masih-Khan E, et al
    Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras.
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0697.
    PubMed     Abstract available


  339. DEBUREAUX PE, Labopin M, Mamez AC, Lapusan S, et al
    Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0690.
    PubMed     Abstract available


  340. ZEBISCH A, Winter G, Kashofer K, Hatzl S, et al
    The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0691.
    PubMed    


  341. MILLER PDE, Snowden JA, De Latour RP, Iacobelli S, et al
    Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0680.
    PubMed     Abstract available


  342. PINANA JL, Perez A, Montoro J, Hernani R, et al
    The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0698.
    PubMed     Abstract available


  343. PARK SS, Min GJ, Park S, Lee SE, et al
    Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0696.
    PubMed    


  344. CABALLERO-VELAZQUEZ T, Calderon-Cabrera C, Lopez-Corral L, Puig N, et al
    Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0670.
    PubMed     Abstract available


  345. GONZALEZ-BARCA E, Boumendil A, Blaise D, Trneny M, et al
    Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantati
    Bone Marrow Transplant. 2019 Sep 20. pii: 10.1038/s41409-019-0650.
    PubMed     Abstract available


  346. LIN Q, Liu X, Han L, Liu L, et al
    Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myeloma.
    Bone Marrow Transplant. 2019 Sep 19. pii: 10.1038/s41409-019-0674.
    PubMed    


  347. RICCI A, Jin Z, Broglie L, Bhatia M, et al
    Healthcare utilization and financial impact of acute-graft-versus host disease among children undergoing allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 Sep 19. pii: 10.1038/s41409-019-0688.
    PubMed     Abstract available


  348. TIRIBELLI M, Palandri F, Sant'Antonio E, Breccia M, et al
    The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0683.
    PubMed     Abstract available


  349. NYKOLYSZYN C, Granata A, Pagliardini T, Castagna L, et al
    Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0682.
    PubMed     Abstract available


  350. TOMORI S, Morishima S, Nishi Y, Nakachi S, et al
    Transplant-related complications are impediments to the success of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia patients in non-complete remission.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0669.
    PubMed     Abstract available


  351. MA Y, Qu C, Dai H, Yin J, et al
    Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0677.
    PubMed    


  352. AMBERGE S, Kramer M, Schrottner P, Heidrich K, et al
    Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0678.
    PubMed     Abstract available


  353. MORRIS C, Chabannon C, Masszi T, Russell N, et al
    Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0676.
    PubMed     Abstract available


  354. SWEISS K, Lee J, Mahmud N, Calip GS, et al
    Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0681.
    PubMed     Abstract available


  355. BENYAMINI N, Lavi N, Zuckerman T, Aviv A, et al
    Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-up.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0671.
    PubMed    


  356. KOVY P, Meggyesi N, Varga L, Balassa K, et al
    Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0656.
    PubMed     Abstract available


  357. XU J, Zhao R, Yang L, Gong H, et al
    Haploidentical stem cells combined with a small dose of umbilical cord blood transplantation exert similar survival outcome of HLA-matched stem cells transplantation in T-cell acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2019 Sep 5. pii: 10.1038/s41409-019-0666.
    PubMed    


  358. STREILER C, Shaikh F, Davis C, Abhyankar S, et al
    Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease.
    Bone Marrow Transplant. 2019 Sep 4. pii: 10.1038/s41409-019-0662.
    PubMed    


  359. FIORENZA S, Routledge D, Collins J, Shipton M, et al
    Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma.
    Bone Marrow Transplant. 2019 Sep 3. pii: 10.1038/s41409-019-0642.
    PubMed    


  360. RAUTENBERG C, Kaivers J, Germing U, Haas R, et al
    Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 3. pii: 10.1038/s41409-019-0664.
    PubMed    


    August 2019
  361. VIVAS YAV, Hungria VTM, Costa LJM, Dos Santos KB, et al
    Up-front autologous hematopoietic stem cell transplantation (AHSCT) from a single Brazilian center.
    Bone Marrow Transplant. 2019 Aug 30. pii: 10.1038/s41409-019-0659.
    PubMed    


  362. HONG CR, Kang HJ, Moon SJ, Oh J, et al
    Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0655.
    PubMed     Abstract available


  363. TAI J, Buras M, Leis J, Noel P, et al
    Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0648.
    PubMed    


  364. FIALA MA, Vosuri V, Goldsmith S, Schroeder MA, et al
    Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0663.
    PubMed    


  365. SHOUVAL R, Vega Y, Fein JA, Danylesko I, et al
    Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0653.
    PubMed     Abstract available


  366. STYCZYNSKI J, Tridello G, Koster L, Iacobelli S, et al
    Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors.
    Bone Marrow Transplant. 2019 Aug 27. pii: 10.1038/s41409-019-0624.
    PubMed     Abstract available


  367. SANDLER RD, Carter S, Kaur H, Francis S, et al
    Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)-time to reappraise with modern diagnostic and treatment strategies?
    Bone Marrow Transplant. 2019 Aug 27. pii: 10.1038/s41409-019-0637.
    PubMed    


  368. CESARO S, Tridello G, van der Werf S, Bader P, et al
    Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0644.
    PubMed     Abstract available


  369. KORDELAS L, Gorgens A, Radtke S, Horn PA, et al
    Allogeneic transplantation of peripheral blood stem cell grafts results in a massive decrease of primitive hematopoietic progenitor frequencies in reconstituted bone marrows.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0645.
    PubMed     Abstract available


  370. RIVAS MM, Berro M, Prates MV, Yantorno S, et al
    Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0640.
    PubMed     Abstract available


  371. SHICHIJO T, Fuji S, Nagler A, Bazarbachi A, et al
    Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0643.
    PubMed     Abstract available


  372. PACCOUD O, Guitard J, Labopin M, Surgers L, et al
    Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0641.
    PubMed     Abstract available


  373. XHAARD A, Launay M, Sicre de Fontbrune F, Michonneau D, et al
    A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.
    Bone Marrow Transplant. 2019 Aug 14. pii: 10.1038/s41409-019-0633.
    PubMed     Abstract available


  374. BONDEELLE L, Gras J, Michonneau D, Houdouin V, et al
    Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Aug 14. pii: 10.1038/s41409-019-0636.
    PubMed    


  375. KERBAUY MN, Mariano L, Seber A, Rocha V, et al
    The impact of low dose busulfan on gonodal function after allogeneic hematopoietic stem cell transplantation for aplastic anemia.
    Bone Marrow Transplant. 2019 Aug 13. pii: 10.1038/s41409-019-0639.
    PubMed    


  376. ATOUI A, El Labban M, Ghaoui N, El Darsa H, et al
    Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2019 Aug 12. pii: 10.1038/s41409-019-0635.
    PubMed    


  377. SWEISS K, Calip GS, Johnson JJ, Rondelli D, et al
    Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2019 Aug 6. pii: 10.1038/s41409-019-0628.
    PubMed     Abstract available


  378. TAVAKOLI ARDAKANI M, Mehrpooya M, Mehdizadeh M, Beiraghi N, et al
    Sertraline treatment decreased the serum levels of interleukin-6 and high-sensitivity C-reactive protein in hematopoietic stem cell transplantation patients with depression; a randomized double-blind, placebo-controlled clinical trial.
    Bone Marrow Transplant. 2019 Aug 5. pii: 10.1038/s41409-019-0623.
    PubMed    


  379. STAFFAS A, van den Brink M
    The intestinal flora is required for post-transplant hematopoiesis in recipients of a hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  380. PREZIOSO L, Manfra I, Bonomini S, Schifano C, et al
    Haploidentical hematopoietic stem cell transplantation in adults using the alphabetaTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  381. BACIGALUPO A, Maria Raiola A, Dominietto A, Di Grazia C, et al
    Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  382. BIELORAI B, Jacoby E, Varda-Bloom N, Hutt D, et al
    Haploidentical hematopoietic stem cell transplantation with alphabetaTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  383. SIDLIK-MUSKATEL R, Reisner Y
    Toward safer haploidnetical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  384. MENDT M, Rezvani K, Shpall E
    Mesenchymal stem cell-derived exosomes for clinical use.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  385. SCHLEGEL P, Lang AM, Matela M, Horrer A, et al
    Ex vivo expansion of autologous, donor-derived NK-, gammadeltaT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  386. SCHLEGEL P, Jung G, Lang AM, Doring M, et al
    ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  387. ANDRE I, Simons L, Ma K, Moirangthem RD, et al
    Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  388. OEVERMANN L, Schulte JH, Hundsdorfer P, Hakimeh D, et al
    HLA-haploidentical hematopoietic stem cell transplantation in pediatric patients with hemoglobinopathies: current practice and new approaches.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  389. PIERINI A, Ruggeri L, Mancusi A, Carotti A, et al
    T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  390. NAGLER A, Ruggeri A
    Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia-an update on behalf of the ALWP of the EBMT.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


  391. LV M, Chang YJ, Huang XJ
    Update of the "Beijing Protocol" haplo-identical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019;54.
    PubMed     Abstract available


    July 2019
  392. TOTANI A, Amin H, Bacchi S, Lewis I, et al
    Vitiligo following stem-cell transplant.
    Bone Marrow Transplant. 2019 Jul 29. pii: 10.1038/s41409-019-0626.
    PubMed     Abstract available


    June 2019
  393. GOMEZ-ARTEAGA A, Mark TM, Guarneri D, Christos PJ, et al
    High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
    Bone Marrow Transplant. 2019 Jun 12. pii: 10.1038/s41409-019-0587.
    PubMed     Abstract available


  394. MILLER KC, Gertz MA, Buadi FK, Hayman SR, et al
    The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2019 Jun 12. pii: 10.1038/s41409-019-0590.
    PubMed     Abstract available


  395. NAKAGAKI M, Button E, Keating A, Marsh J, et al
    Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation.
    Bone Marrow Transplant. 2019 Jun 11. pii: 10.1038/s41409-019-0586.
    PubMed    


  396. ZHAO Y, Shi J, Li X, Wang J, et al
    Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2019 Jun 4. pii: 10.1038/s41409-019-0577.
    PubMed    


  397. RUUTU T, van der Werf S, van Biezen A, Backman JT, et al
    Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2019 Jun 3. pii: 10.1038/s41409-019-0579.
    PubMed     Abstract available


    May 2019
  398. YANO S, Yokoyama H, Yanada M, Mori J, et al
    Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0571.
    PubMed     Abstract available


  399. DIETRICH S, Dreger P, Hermine O, Kyriakou C, et al
    Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0583.
    PubMed     Abstract available


  400. TUCCI F, Frittoli M, Barzaghi F, Calbi V, et al
    Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0573.
    PubMed     Abstract available


  401. RUGGERI A, Labopin M, Savani B, Paviglianiti A, et al
    Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0582.
    PubMed     Abstract available


  402. VIJAYVARGIYA P, Gonsalves W, Burton D, Hogan WJ, et al
    Increased fecal primary bile acids in multiple myeloma with engraftment syndrome diarrhea after stem cell transplant.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0581.
    PubMed     Abstract available


  403. HEUMULLER A, Wehrle J, Stosch J, Niemoller C, et al
    Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donors.
    Bone Marrow Transplant. 2019 May 30. pii: 10.1038/s41409-019-0575.
    PubMed    


  404. KAITO S, Sekiya N, Najima Y, Suzuki T, et al
    Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 May 29. pii: 10.1038/s41409-019-0541.
    PubMed    


  405. BIRAN N, Rowley SD, Vesole DH, Zhang S, et al
    A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2019 May 17. pii: 10.1038/s41409-019-0534.
    PubMed     Abstract available


  406. LANGEBRAKE C, Admiraal R, van Maarseveen E, Bonnin A, et al
    Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 May 17. pii: 10.1038/s41409-019-0538.
    PubMed    


  407. IIDA M, Kodera Y, Dodds A, Ho AYL, et al
    Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0554.
    PubMed     Abstract available


  408. BABOR F, Peters C, Manser AR, Glogova E, et al
    Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0543.
    PubMed     Abstract available


  409. AL HAMED R, Bazarbachi AH, Mohty M
    Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0548.
    PubMed     Abstract available


  410. SENN-MALASHONAK A, Wallek S, Schmidt K, Rosenhagen A, et al
    Psychophysical effects of an exercise therapy during pediatric stem cell transplantation: a randomized controlled trial.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0535.
    PubMed     Abstract available


  411. PUNATAR S, Mohite A, Gokarn A, Nayak L, et al
    Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0545.
    PubMed    


  412. GUILLAUME T, Malard F, Magro L, Labopin M, et al
    Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0536.
    PubMed     Abstract available


  413. AXT L, Naumann A, Toennies J, Haen SP, et al
    Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0544.
    PubMed     Abstract available


  414. ESTEVES I, Santos FPS, Fernandes JF, Seber A, et al
    Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0521.
    PubMed     Abstract available


  415. KATOH D, Ochi Y, Hiramoto N, Morita M, et al
    Parvovirus B19 infection in adult patients after allogeneic stem cell transplantation: our experience of five cases and literature review.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0533.
    PubMed    


  416. NISHIWAKI S, Miyamura K, Kanda Y, Takanashi M, et al
    A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0542.
    PubMed    


  417. CAMPAGNA A, Gianfelici V, Antolino G, Pelliccia S, et al
    Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation.
    Bone Marrow Transplant. 2019 May 8. pii: 10.1038/s41409-019-0532.
    PubMed    


    April 2019
  418. OEVERMANN L, Zimmermann C, Voigt S, Kunkele A, et al
    Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications.
    Bone Marrow Transplant. 2019 Apr 15. pii: 10.1038/s41409-019-0530.
    PubMed    


  419. YAMASAKI S, Aoki J, Mori J, Mizuno S, et al
    Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.
    Bone Marrow Transplant. 2019 Apr 10. pii: 10.1038/s41409-019-0527.
    PubMed    


  420. WIENER L, Hoag JA, Pelletier W, Shah NN, et al
    Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors.
    Bone Marrow Transplant. 2019 Apr 10. pii: 10.1038/s41409-019-0515.
    PubMed     Abstract available


  421. SIDIQI MH, Nadiminti K, Al Saleh AS, Meleveedu K, et al
    Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function.
    Bone Marrow Transplant. 2019 Apr 8. pii: 10.1038/s41409-019-0524.
    PubMed     Abstract available


  422. LUBKING A, Dreimane A, Sandin F, Isaksson C, et al
    Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.
    Bone Marrow Transplant. 2019 Apr 8. pii: 10.1038/s41409-019-0513.
    PubMed     Abstract available


  423. DUARTE RF, Labopin M, Bader P, Basak GW, et al
    Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0516.
    PubMed     Abstract available


  424. SOLH MM, Dickhaus E, Solomon SR, Morris LE, et al
    Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0522.
    PubMed     Abstract available


  425. BUHLER S, Baldomero H, Ferrari-Lacraz S, Nunes JM, et al
    High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0520.
    PubMed     Abstract available


    March 2019
  426. DANIEL-MORENO A, Lamsfus-Calle A, Raju J, Antony JS, et al
    CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 22. pii: 10.1038/s41409-019-0510.
    PubMed     Abstract available


  427. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 21. pii: 10.1038/s41409-019-0509.
    PubMed     Abstract available


  428. KISHIMOTO K, Hasegawa D, Kawasaki K, Tamura A, et al
    Early posttransplant plasma ADAMTS13 activity reduction in stem cell transplantation: a prospective study of 46 pediatric patients.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0506.
    PubMed    


  429. GRANATA A, Furst S, Bramanti S, Legrand F, et al
    Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0500.
    PubMed     Abstract available


  430. KARLAS T, Weisse T, Petroff D, Beer S, et al
    Author Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0512.
    PubMed     Abstract available


  431. KIMURA F, Kanda J, Ishiyama K, Yabe T, et al
    ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2019 Mar 13. pii: 10.1038/s41409-019-0496.
    PubMed     Abstract available


  432. LUO Y, Jin M, Tan Y, Zhao Y, et al
    Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 13. pii: 10.1038/s41409-019-0502.
    PubMed     Abstract available


  433. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2019 Mar 12. pii: 10.1038/s41409-019-0504.
    PubMed     Abstract available


  434. HOLDERRIED TAW, Fraccaroli A, Schumacher M, Heine A, et al
    The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0498.
    PubMed     Abstract available


  435. LA ROCCA U, Perrone MP, Piciocchi A, Cinti P, et al
    Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0497.
    PubMed    


    February 2019
  436. KARLAS T, Weisse T, Petroff D, Beer S, et al
    Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement.
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0464.
    PubMed     Abstract available


  437. BAUMGARTNER A, Moesch M, Zumsteg M, Struja T, et al
    Predictors of impaired bone health in long-term survivors after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0484.
    PubMed     Abstract available


  438. KATO K, Mori T, Kim SW, Sawa M, et al
    Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantati
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0491.
    PubMed    


  439. HUBEL K, Re A, Boumendil A, Finel H, et al
    Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2019 Feb 25. pii: 10.1038/s41409-019-0480.
    PubMed     Abstract available


  440. KOO J, Silverman S, Nuechterlein B, Keating AK, et al
    Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors.
    Bone Marrow Transplant. 2019 Feb 19. pii: 10.1038/s41409-019-0479.
    PubMed     Abstract available


  441. MIZUNO S, Kawamura K, Hanamura I, Sunami K, et al
    Efficacy and safety of autologous stem cell transplantation in patients aged >/= 65 years with multiple myeloma in the era of novel agents.
    Bone Marrow Transplant. 2019 Feb 19. pii: 10.1038/s41409-019-0478.
    PubMed     Abstract available


  442. FAYARD A, Daguenet E, Blaise D, Chevallier P, et al
    Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem
    Bone Marrow Transplant. 2019 Feb 15. pii: 10.1038/s41409-019-0475.
    PubMed     Abstract available


  443. GABALLA A, Stikvoort A, Onfelt B, Mattsson J, et al
    T-cell frequencies of CD8(+) gammadelta and CD27(+) gammadelta cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 Feb 5. pii: 10.1038/s41409-019-0462.
    PubMed     Abstract available


  444. ITONAGA H, Ishiyama K, Aoki K, Aoki J, et al
    Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0469.
    PubMed     Abstract available


  445. JOHANSSON JE, Bratel J, Hardling M, Heikki L, et al
    Cryotherapy as prophylaxis against oral mucositis after high-dose melphalan and autologous stem cell transplantation for myeloma: a randomised, open-label, phase 3, non-inferiority trial.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0468.
    PubMed     Abstract available


  446. SENGELOV H, Petersen PM, Fog L, Schmidt M, et al
    Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0470.
    PubMed    


  447. OKAMOTO Y, Kudo K, Tabuchi K, Tomizawa D, et al
    Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0461.
    PubMed     Abstract available


  448. FARNAULT L, Venton G, Pourroy B, Jourde-Chiche N, et al
    Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0467.
    PubMed    


  449. BATTIPAGLIA G, Boumendil A, Labopin M, Ciceri F, et al
    Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0459.
    PubMed     Abstract available


  450. SINGER S, Sharma N, Dean R, Zhao Q, et al
    BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0463.
    PubMed     Abstract available


  451. ZHANG YY, Mo XD, Zhang XH, Xu LP, et al
    FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.
    Bone Marrow Transplant. 2019 Feb 1. pii: 10.1038/s41409-019-0456.
    PubMed     Abstract available


    January 2019
  452. JESSOP H, Farge D, Saccardi R, Alexander T, et al
    General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT
    Bone Marrow Transplant. 2019 Jan 31. pii: 10.1038/s41409-019-0430.
    PubMed     Abstract available


  453. BENOIT SW, Dixon BP, Goldstein SL, Bennett MR, et al
    A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 30. pii: 10.1038/s41409-018-0428.
    PubMed     Abstract available


  454. POIREL HA, Vanspauwen M, Macq G, De Geyndt A, et al
    Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.
    Bone Marrow Transplant. 2019 Jan 29. pii: 10.1038/s41409-019-0458.
    PubMed     Abstract available


  455. ABIDI MZ, Hari P, Chen M, Kim S, et al
    Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study.
    Bone Marrow Transplant. 2019 Jan 29. pii: 10.1038/s41409-019-0457.
    PubMed     Abstract available


  456. WEN Q, Kong Y, Zhao HY, Zhang YY, et al
    G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 25. pii: 10.1038/s41409-019-0449.
    PubMed     Abstract available


  457. MARIOTTI J, Granata A, Bramanti S, Devillier R, et al
    The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2019 Jan 24. pii: 10.1038/s41409-019-0453.
    PubMed     Abstract available


  458. FUJIWARA SI, Kanda J, Tatara R, Ogawa H, et al
    Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 22. pii: 10.1038/s41409-019-0434.
    PubMed     Abstract available


  459. GUTIERREZ-GARCIA G, Cibeira MT, Rovira M, Fernandez de Larrea C, et al
    Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0447.
    PubMed     Abstract available


  460. PHULL P, Sanchorawala V, Brauneis D, Sloan JM, et al
    High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0440.
    PubMed     Abstract available


  461. FU H, Zhang X, Han T, Mo X, et al
    Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0435.
    PubMed     Abstract available


  462. WIKTOR-JEDRZEJCZAK W, Drozd-Sokolowska J, Eikema DJ, Hoek J, et al
    EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0448.
    PubMed     Abstract available


  463. KE P, Bao X, Qiu H, Zhuang J, et al
    Central nervous system complications caused by 3-4 grade aGVHD in adult patients occurred in HLA-mismatched recipients majorly after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0443.
    PubMed    


  464. ABADIR E, Bryant C, Larsen S, Clark GJ, et al
    Targeting the niche: depleting haemopoietic stem cells with targeted therapy.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0445.
    PubMed     Abstract available


  465. ADKINS BD, Savani BN, Booth GS
    Transgender individuals represent an overlooked population amongst stem cell donors.
    Bone Marrow Transplant. 2019 Jan 18. pii: 10.1038/s41409-019-0437.
    PubMed    


  466. HINO T, Imi T, Hangaishi A, Kamoda Y, et al
    Escape hematopoiesis by donor-derived 6pLOH(+) hematopoietic stem cells in a marrow transplant recipient with late graft failure.
    Bone Marrow Transplant. 2019 Jan 10. pii: 10.1038/s41409-018-0420.
    PubMed    


    December 2018
  467. WANG RC, Mori S, Zhu X, Varela JC, et al
    Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome.
    Bone Marrow Transplant. 2018 Dec 18. pii: 10.1038/s41409-018-0407.
    PubMed    


  468. USTUN C, Young JH, Papanicolaou GA, Kim S, et al
    Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Dec 13. pii: 10.1038/s41409-018-0401.
    PubMed     Abstract available


  469. ALATRASH G, Kidwell KM, Thall PF, Di Stasi A, et al
    Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.
    Bone Marrow Transplant. 2018 Dec 10. pii: 10.1038/s41409-018-0405.
    PubMed     Abstract available


  470. UMEDA K, Yabe H, Kato K, Imai K, et al
    Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0418.
    PubMed     Abstract available


  471. INAMOTO Y, Valdes-Sanz N, Ogawa Y, Alves M, et al
    Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0340.
    PubMed     Abstract available


  472. BONDANZA A, Ruggeri L, Noviello M, Eikema DJ, et al
    Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0351.
    PubMed     Abstract available


  473. ZHAO J, Zu Y, Han L, Zhang Y, et al
    Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion.
    Bone Marrow Transplant. 2018 Dec 5. pii: 10.1038/s41409-018-0409.
    PubMed     Abstract available


    November 2018
  474. HIGASHINO HR, Marchi AP, Martins RCR, Batista MV, et al
    Colistin-resistant Klebsiella pneumoniae co-harboring KPC and MCR-1 in a Hematopoietic Stem Cell Transplantation Unit.
    Bone Marrow Transplant. 2018 Nov 30. pii: 10.1038/s41409-018-0416.
    PubMed    


  475. BAIER DM, Hofmann JA, Fischer H, Rall G, et al
    Very low error rates of NGS-based HLA typing at stem cell donor recruitment question the need for a standard confirmatory typing step before donor work-up.
    Bone Marrow Transplant. 2018 Nov 30. pii: 10.1038/s41409-018-0411.
    PubMed    


  476. JELINEK T, Adamusova L, Popkova T, Tvrda I, et al
    Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma.
    Bone Marrow Transplant. 2018 Nov 20. pii: 10.1038/s41409-018-0396.
    PubMed     Abstract available


  477. YANG J, Jiang J, Cai Y, Li S, et al
    Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malig
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0382.
    PubMed     Abstract available


  478. GOWDA L, Shah M, Badar I, Bashir Q, et al
    Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0392.
    PubMed     Abstract available


  479. KUMAR A, Reljic T, Hamadani M, Mohty M, et al
    Antithymocyte globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis.
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0393.
    PubMed     Abstract available


  480. WULF G, Hasenkamp J, Jung W, Wilhelm C, et al
    Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.
    Bone Marrow Transplant. 2018 Nov 9. pii: 10.1038/s41409-018-0360.
    PubMed     Abstract available


  481. TROVILLION EM, Gloude NJ, Anderson EJ, Morris GP, et al
    Relationship of post-transplant thymopoiesis with CD4(+)FoxP3(+) regulatory T cell recovery associated with freedom from chronic graft versus host disease.
    Bone Marrow Transplant. 2018 Nov 9. pii: 10.1038/s41409-018-0394.
    PubMed    


  482. PAGLIARDINI T, Harbi S, Furst S, Castagna L, et al
    Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0387.
    PubMed     Abstract available


  483. GERULL S, Tschan-Plessl A, Mathew R, Nair G, et al
    Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0376.
    PubMed    


  484. ROS-SOTO J, Anthias C, Madrigal A, Snowden JA, et al
    Vitamin D: is it important in haematopoietic stem cell transplantation? A review.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0377.
    PubMed     Abstract available


  485. KNOLL BM, Seiter K, Phillips A, Soave R, et al
    Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0389.
    PubMed    


  486. WEBER D, Weber M, Hippe K, Ghimire S, et al
    Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0381.
    PubMed     Abstract available


  487. NORMAN JE, Schouten HC, Dreger P, Robinson SP, et al
    The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0372.
    PubMed     Abstract available


  488. GALLANAGH M, Shaw O, Kaur H, Raj K, et al
    Successful engraftment in recipients of haploidentical stem cells with donor-specific antibodies: role of flow cytometric cross-match.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0384.
    PubMed    


  489. GHILARDI G, Pabst T, Jeker B, Muller R, et al
    Melphalan dose in myeloma patients >/=65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0379.
    PubMed     Abstract available


  490. SIDIQI MH, Aljama MA, Muchtar E, Buadi FK, et al
    Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0388.
    PubMed     Abstract available


  491. GIEBEL S, Marks DI, Boissel N, Baron F, et al
    Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute L
    Bone Marrow Transplant. 2018 Nov 1. pii: 10.1038/s41409-018-0373.
    PubMed     Abstract available


  492. EICHENBERGER EM, Soave R, Zappetti D, Small CB, et al
    Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Nov 1. pii: 10.1038/s41409-018-0386.
    PubMed     Abstract available


    October 2018
  493. PATEL SS, Rybicki LA, Corrigan D, Dumont C, et al
    Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Oct 30. pii: 10.1038/s41409-018-0380.
    PubMed     Abstract available


  494. RIVERA D, Bastida JM, Lopez-Corral L, Sanchez-Guijo F, et al
    Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 24. pii: 10.1038/s41409-018-0368.
    PubMed    


  495. DANYLESKO I, Bukauskas A, Paulson M, Peceliunas V, et al
    Anti-alpha4beta7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Oct 24. pii: 10.1038/s41409-018-0364.
    PubMed     Abstract available


  496. KAROW A, Wilhelm A, Ammann RA, Baerlocher GM, et al
    Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow.
    Bone Marrow Transplant. 2018 Oct 23. pii: 10.1038/s41409-018-0353.
    PubMed     Abstract available


  497. HARASHIMA S, Yoneda R, Horie T, Fujioka Y, et al
    Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 23. pii: 10.1038/s41409-018-0371.
    PubMed     Abstract available


  498. JABBOUR J, Manana B, Sakr M, Zahreddine A, et al
    The impact of counseling on nutritional status among hematopoietic stem cell recipients: results of a randomized controlled trial.
    Bone Marrow Transplant. 2018 Oct 22. pii: 10.1038/s41409-018-0366.
    PubMed    


  499. ZIEGLER AK, Abend M, Port M, Dammann E, et al
    Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0359.
    PubMed    


  500. SHAH MV, Saliba RM, Rondon G, Chen J, et al
    Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0367.
    PubMed     Abstract available


  501. HAYAKAWA J, Miyamura D, Kimura SI, Gomyo A, et al
    Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0365.
    PubMed     Abstract available


  502. KALOYANNIDIS P, Shaibani EA, Apostolidis I, Kanfar S, et al
    Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0362.
    PubMed    


  503. DE LA HOZ A, Foolad F, Gallegos C, Kornblau S, et al
    Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease.
    Bone Marrow Transplant. 2018 Oct 15. pii: 10.1038/s41409-018-0363.
    PubMed    


  504. KUROSAWA S, Yamaguchi T, Oshima K, Yanagisawa A, et al
    Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0343.
    PubMed    


  505. BAE SK, Gushima T, Saito N, Yamanaka I, et al
    HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0355.
    PubMed    


  506. MOUKALLED NM, El Darsa H, Haibe Y, Massoud R, et al
    Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0347.
    PubMed    


  507. PAHNKE S, Egeland T, Halter J, Hagglund H, et al
    Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0350.
    PubMed     Abstract available


  508. DOS SANTOS KB, Costa LJM, Bettarello G, da Matta Abreu M, et al
    LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0349.
    PubMed    


  509. PINGEL J, Wang T, Hagenlocher Y, Hernandez-Frederick CJ, et al
    The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.
    Bone Marrow Transplant. 2018 Oct 2. pii: 10.1038/s41409-018-0345.
    PubMed     Abstract available


    September 2018
  510. SMELAND KB, Loge JH, Aass HCD, Aspelin T, et al
    Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity.
    Bone Marrow Transplant. 2018 Sep 27. pii: 10.1038/s41409-018-0342.
    PubMed    


  511. JAIME-PEREZ JC, Salazar-Cavazos L, Aguilar-Calderon P, Herrera-Garza JL, et al
    Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country.
    Bone Marrow Transplant. 2018 Sep 21. pii: 10.1038/s41409-018-0338.
    PubMed     Abstract available


  512. SALEEM MS, Aljurf M, Srivastava A, Shamsi T, et al
    Challenges in managing graft-versus-host disease in developing countries: a perspective.
    Bone Marrow Transplant. 2018 Sep 20. pii: 10.1038/s41409-018-0333.
    PubMed     Abstract available


  513. BONIFAZI F, Dan E, Labopin M, Sessa M, et al
    Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
    Bone Marrow Transplant. 2018 Sep 19. pii: 10.1038/s41409-018-0335.
    PubMed     Abstract available


  514. NAFTULIN JS, Penzi LR, Manatis-Lornell A, Yasuda MR, et al
    Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults.
    Bone Marrow Transplant. 2018 Sep 13. pii: 10.1038/s41409-018-0309.
    PubMed    


    August 2018
  515. KAMEDA K, Kimura SI, Misaki Y, Yoshimura K, et al
    Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0330.
    PubMed     Abstract available


  516. TSANG ES, Villa D, Loscocco F, Visani G, et al
    High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0328.
    PubMed    


  517. LIN RJ, Elko TA, Perales MA, Alexander K, et al
    End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0311.
    PubMed     Abstract available


  518. MOHANAN E, Panetta JC, Lakshmi KM, Edison ES, et al
    Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0276.
    PubMed     Abstract available


  519. CHAULAGAIN CP, Sprague KA, Pilichowska M, Cowan J, et al
    Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0299.
    PubMed     Abstract available


  520. YAKUSHIJIN K, Ikezoe T, Ohwada C, Kudo K, et al
    Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0304.
    PubMed     Abstract available


  521. KANELLOPOULOS A, Kaparou M, Xenou E, Paneesha S, et al
    Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0297.
    PubMed     Abstract available


  522. LADETTO M, Bottcher S, Kroger N, Pulsipher MA, et al
    Methods and role of minimal residual disease after stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0307.
    PubMed     Abstract available


  523. PICCALUGA PP, Rapezzi D, Gazzola A, Malagola M, et al
    Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0268.
    PubMed    


  524. MILLER KC, Gertz MA, Buadi FK, Hayman SR, et al
    Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0302.
    PubMed     Abstract available


  525. GUNES G, Goker H, Demiroglu H, Malkan UY, et al
    Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0303.
    PubMed     Abstract available


  526. MATSUDA K, Honda A, Arai S, Maki H, et al
    Retrospective analysis on transient recurrence of steroid-sensitive acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0274.
    PubMed    


  527. DABAS R, Dharmani-Khan P, Modi M, Van Slyke T, et al
    Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0296.
    PubMed     Abstract available


  528. BITTENCOURT MCB, Mariano L, Moreira F, Schmidt-Filho J, et al
    Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0250.
    PubMed    


  529. KRAFT S, Bollinger N, Bodenmann B, Heim D, et al
    High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0293.
    PubMed     Abstract available


  530. PHILIPPE M, Neely M, Rushing T, Bertrand Y, et al
    Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0281.
    PubMed     Abstract available


  531. MARTELIN E, Volin L, Itala-Remes M, Niittyvuopio R, et al
    Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0290.
    PubMed    


  532. DOUCETTE K, Tian X, Chawla U, Jain NA, et al
    Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0282.
    PubMed    


  533. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0294.
    PubMed    


  534. VARGA C, Comenzo RL
    High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0284.
    PubMed     Abstract available


  535. KEREP AZ, Broome J, Pirsl F, Curtis LM, et al
    Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0224.
    PubMed     Abstract available


  536. PERIC Z, Skegro I, Durakovic N, Desnica L, et al
    Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0140.
    PubMed    


  537. MUKHERJEE A, Ekinci E, Scholoff A, Obi G, et al
    Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0285.
    PubMed    


  538. KONISHI Y, Kondo T, Nakao K, Asagoe K, et al
    Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0287.
    PubMed    


  539. SUGITA J, Kagaya Y, Miyamoto T, Shibasaki Y, et al
    Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0279.
    PubMed     Abstract available


  540. BALDOMERO H, Aljurf M, Zaidi SZA, Hashmi SK, et al
    Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0275.
    PubMed     Abstract available


  541. VAN DER HEIDEN PLJ, Arbous MS, van Beers EJ, van den Bergh WM, et al
    Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0277.
    PubMed     Abstract available


    July 2018
  542. HIRANO M, Jimbo K, Ogawa M, Ochi K, et al
    Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0202.
    PubMed    


  543. SAITO A, Nishikawa T, Oyoshi T, Nakagawa S, et al
    Giant radiation-induced cavernous haemangioma before reduced-intensity bone marrow transplantation for acute lymphoblastic leukaemia.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0272.
    PubMed    


  544. CHEN YB, McCarthy PL, Hahn T, Holstein SA, et al
    Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agents.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0269.
    PubMed     Abstract available


  545. BHUTANI D, Jaiyeoba C, Kim S, Naylor P, et al
    Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0270.
    PubMed    


  546. HAGEN PA, Adams W, Smith S, Tsai S, et al
    Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0267.
    PubMed    


  547. TAY J, Daly A, Jamani K, Labelle L, et al
    Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0265.
    PubMed     Abstract available


  548. GONSALVES WI, Buadi FK, Ailawadhi S, Bergsagel PL, et al
    Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0264.
    PubMed     Abstract available


  549. YANG B, Yu R, Cai L, Bin Guo, et al
    Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0239.
    PubMed     Abstract available


    June 2018
  550. TOMIZAWA D, Yoshida M, Kondo T, Miyamura T, et al
    Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
    Bone Marrow Transplant. 2018 Jun 29. pii: 10.1038/s41409-018-0273.
    PubMed     Abstract available


  551. TANG S, Shen H, Qu C, Dai H, et al
    Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 25. pii: 10.1038/s41409-018-0249.
    PubMed     Abstract available


  552. CHUNG H, Hong KT, Lee JW, Rhee SJ, et al
    Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.
    Bone Marrow Transplant. 2018 Jun 18. pii: 10.1038/s41409-018-0260.
    PubMed     Abstract available


  553. HARI P, Reece DE, Randhawa J, Flomenberg N, et al
    Final outcomes of escalated melphalan 280 mg/m(2) with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0261.
    PubMed     Abstract available


  554. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0262.
    PubMed    


  555. MALARD F, Gasc C, Plantamura E, Dore J, et al
    High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0254.
    PubMed    


  556. WONG E, Davis JE, Grigg A, Szer J, et al
    Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0244.
    PubMed     Abstract available


  557. SOLANO C, Gimenez E, Albert E, Mateo EM, et al
    Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0251.
    PubMed     Abstract available


  558. GABELLI M, Zecca M, Messina C, Carraro E, et al
    Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0259.
    PubMed     Abstract available


  559. HOCHBERG J, Zahler S, Geyer MB, Chen N, et al
    The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuke
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0247.
    PubMed     Abstract available


  560. NADEMI Z, Wynn RF, Slatter M, Hughes SM, et al
    Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0246.
    PubMed    


  561. MOOR I, Bacher VU, Jeker B, Taleghani BM, et al
    Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0245.
    PubMed    


  562. DOESCHER A, Casper J, Kraemer D, Kapels HH, et al
    Digital PCR to assess platelet recovery after stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0238.
    PubMed    


  563. WHITE PS, Phull P, Brauneis D, Sloan JM, et al
    High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0242.
    PubMed    


  564. AL-SAUD B, Al-Jomaie M, Al-Ghonaium A, Al-Ahmari A, et al
    Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0219.
    PubMed     Abstract available


  565. GRIFFIN SP, Wheeler SE, Wiggins LE, Murthy HS, et al
    Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0240.
    PubMed     Abstract available


  566. ROBINSON SP, Boumendil A, Finel H, Dreger P, et al
    High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0196.
    PubMed     Abstract available


  567. SORENSEN CD, Moller BK, Olesen G, Hokland P, et al
    Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0229.
    PubMed    


  568. SCHOEMANS HM, Lee SJ, Ferrara JL, Wolff D, et al
    EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
    Bone Marrow Transplant. 2018 Jun 5. pii: 10.1038/s41409-018-0204.
    PubMed    


    May 2018
  569. BURT RK, Han X, Gozdziak P, Yaung K, et al
    Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome.
    Bone Marrow Transplant. 2018 May 31. pii: 10.1038/s41409-018-0173.
    PubMed     Abstract available


  570. MA CKK, Garcia-Cadenas I, Fox ML, Ai S, et al
    Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0215.
    PubMed    


  571. SUREDA A, Dreger P, Bishop MR, Kroger N, et al
    Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0214.
    PubMed     Abstract available


  572. JAIN T, Kunze KL, Temkit M, Partain DK, et al
    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0226.
    PubMed     Abstract available


  573. GANETSKY A, Frey NV, Hexner EO, Loren AW, et al
    Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0236.
    PubMed     Abstract available


  574. KATO M, Kurata M, Kanda J, Kato K, et al
    Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0221.
    PubMed     Abstract available


  575. GOKBUGET N, Canaani J, Nagler A, Bishop M, et al
    Prevention and treatment of relapse after stem cell transplantation with immunotherapy.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0232.
    PubMed     Abstract available


  576. FALKENBURG F, Ruggiero E, Bonini C, Porter D, et al
    Prevention and treatment of relapse after stem cell transplantation by cellular therapies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0227.
    PubMed     Abstract available


  577. PHAN TL, Pritchett JC, Leifer C, Zerr DM, et al
    HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0225.
    PubMed     Abstract available


  578. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0223.
    PubMed    


  579. MANJAPPA S, Fiala MA, King J, Kohnen DA, et al
    The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0216.
    PubMed    


  580. JACOBSE J, Mensink H, van der Stoep-Yap MYEC, Kollen WJW, et al
    Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0231.
    PubMed    


  581. DAMLAJ M, Alaskar A, Ghazi S, Alahmari B, et al
    Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective.
    Bone Marrow Transplant. 2018 May 9. pii: 10.1038/s41409-018-0208.
    PubMed    


  582. TKACZYK ER, Chen F, Wang J, Gandelman JS, et al
    Overcoming human disagreement assessing erythematous lesion severity on 3D photos of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0211.
    PubMed    


  583. SATO T, Seto A, Kagaya Y, Kawashima N, et al
    Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0197.
    PubMed    


  584. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0206.
    PubMed     Abstract available


  585. TAGEJA N, Korde N, Kazandjian D, Panch S, et al
    Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0170.
    PubMed     Abstract available


  586. KONUMA T, Kohara C, Watanabe E, Mizukami M, et al
    Circulating monocyte subsets in human chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0187.
    PubMed     Abstract available


  587. SAAD A, Taneja A, Di Stasi A, Sarmad R, et al
    Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0185.
    PubMed    


  588. ASLAM HM, Yousuf S, Kassim A, Iqbal SM, et al
    Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0193.
    PubMed     Abstract available


  589. CHEN Y, Xu LP, Zhang XH, Chen H, et al
    Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.
    Bone Marrow Transplant. 2018 May 3. pii: 10.1038/s41409-018-0175.
    PubMed    


  590. SELLMANN L, Rabe K, Bunting I, Dammann E, et al
    Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 2. pii: 10.1038/s41409-018-0176.
    PubMed     Abstract available


    April 2018
  591. YANG L, Tan Y, Shi J, Zhao Y, et al
    Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
    Bone Marrow Transplant. 2018 Apr 30. pii: 10.1038/s41409-018-0184.
    PubMed    


  592. GUTIERREZ-GARCIA G, Rovira M, Magnano L, Rosinol L, et al
    Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 29. pii: 10.1038/s41409-018-0189.
    PubMed     Abstract available


  593. PRESTES DP, Mendes C, Batista MV, Ramos JF, et al
    A case-series of Toxoplasmosis in hematopoietic stem cell transplantation: still a concern for endemic countries.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0179.
    PubMed    


  594. AERTS-KAYA F, Koca G, Sharafi P, Sayla FC, et al
    Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0192.
    PubMed    


  595. NOGUCHI M, Moritake H, Kamimura S, Sonoda M, et al
    Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0180.
    PubMed    


  596. SOLANO C, Talaya A, Gimenez E, Albert E, et al
    Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0191.
    PubMed    


  597. BROWNBACK KR, Pitts LR, Abhyankar S
    Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0182.
    PubMed    


  598. JODELE S, Dandoy CE, Myers K, Wallace G, et al
    High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
    Bone Marrow Transplant. 2018 Apr 19. pii: 10.1038/s41409-018-0159.
    PubMed     Abstract available


  599. HOROWITZ M, Schreiber H, Elder A, Heidenreich O, et al
    Epidemiology and biology of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0171.
    PubMed    


  600. PEREZ L, Fernandez H, Horna P, Riches M, et al
    Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0163.
    PubMed     Abstract available


  601. GRECO R, Ciceri F, Noviello M, Bondanza A, et al
    Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.
    Bone Marrow Transplant. 2018 Apr 17. pii: 10.1038/s41409-018-0167.
    PubMed    


  602. PERIC Z, Wilson J, Durakovic N, Ostojic A, et al
    Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0172.
    PubMed     Abstract available


  603. BATTIPAGLIA G, Ruggeri A, Labopin M, Volin L, et al
    Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0169.
    PubMed     Abstract available


    March 2018
  604. NAITHANI R, Dayal N, Pathak S, Rai R, et al
    Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma.
    Bone Marrow Transplant. 2018 Mar 29. pii: 10.1038/s41409-018-0174.
    PubMed    


  605. CASTAGNOLA E, Bagnasco F, Menoni S, Muraca M, et al
    Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GIT
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0160.
    PubMed    


  606. YAHNG SA, Park SS, Jeon YW, Yoon JH, et al
    Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia.
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0154.
    PubMed     Abstract available


  607. GAAFAR A, Sheereen A, Almohareb F, Eldali A, et al
    Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0123.
    PubMed     Abstract available


  608. VAN DER WAGEN L, Te Boome L, Schiffler M, Nijhof I, et al
    Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0158.
    PubMed     Abstract available


  609. GASSAS A, Sivaprakasam P, Cummins M, Breslin P, et al
    High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0157.
    PubMed     Abstract available


  610. BENEVENTI F, Locatelli E, Simonetta M, Cavagnoli C, et al
    Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0149.
    PubMed     Abstract available


  611. SCHMIDT V, Niederwieser D, Schenk T, Behre G, et al
    Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0135.
    PubMed    


  612. KORDELAS L, da Silva Nardi F, Wagner B, Ditschkowski M, et al
    Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 14. pii: 10.1038/s41409-018-0145.
    PubMed     Abstract available


  613. RICHARDS S, Choo S, Mechinaud F, Cole T, et al
    Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2018 Mar 13. pii: 10.1038/s41409-018-0125.
    PubMed    


  614. CHUA CC, Lim HY, Chai KL, Ong J, et al
    Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0152.
    PubMed     Abstract available


  615. TROEGER H, Hering NA, Bojarski C, Fromm A, et al
    Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0144.
    PubMed    


  616. DEBALS-GONTHIER M, Siani C, Faucher C, Touzani R, et al
    Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0133.
    PubMed     Abstract available


  617. LAMB LS, Pillai S, Langford S, Bowersock J, et al
    Clinical-scale manufacturing of gammadelta T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0130.
    PubMed    


  618. PERIC Z, Botti S, Stringer J, Krawczyk J, et al
    Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0137.
    PubMed     Abstract available


  619. CHENG Z, Zhou L, Hu K, Dai Y, et al
    Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0146.
    PubMed     Abstract available


    February 2018
  620. GJAERDE LK, Schmidt M, Sengelov H
    Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Feb 28. pii: 10.1038/s41409-018-0131.
    PubMed    


  621. AVIVI I, Boumendil A, Finel H, Nagler A, et al
    Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-017-0063.
    PubMed     Abstract available


  622. BUBALO J, Mulverhill K, Meyers G, Hayes-Lattin B, et al
    A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoie
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-018-0106.
    PubMed     Abstract available


  623. SARMIENTO M, Ramirez P, Parody R, Salas MQ, et al
    Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0117.
    PubMed     Abstract available


  624. MARCHESI F, Capria S, Giannarelli D, Trisolini SM, et al
    BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0120.
    PubMed    


  625. WATTS MJ, Ings SJ, Dorman J, Rabin N, et al
    Use of split peripheral blood stem cell harvests in myeloma identifies functional preservation of progenitor cells cryopreserved for several years and demonstrates no functional damage to the bone marrow microenvironment.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0121.
    PubMed    


  626. HSU YT, Tsai HJ, Chang JS, Li SS, et al
    Stem cell transplantation for T-cell lymphomas in Taiwan.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0116.
    PubMed     Abstract available


  627. BORCHERT-MORLINS B, Memaran N, Sauer M, Maecker-Kolhoff B, et al
    Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age.
    Bone Marrow Transplant. 2018 Feb 9. pii: 10.1038/s41409-018-0104.
    PubMed     Abstract available


  628. MASHEGU H, Smith L, Li Y, Seif A, et al
    The role of peritoneal drainage in veno-occlusive disease in pediatric patients post hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0113.
    PubMed    


  629. TETU P, Jachiet M, de Masson A, Hurabielle C, et al
    Chronic graft versus host disease presenting as lichen planus pigmentosus.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0110.
    PubMed    


  630. OZDOGU H, Boga C, Yeral M, Kozanoglu I, et al
    Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0111.
    PubMed     Abstract available


  631. YOO KH, Kang D, Kim IR, Choi EK, et al
    Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0097.
    PubMed     Abstract available


  632. ZHANG Q, Zhou Y, Majaw JK, Xu J, et al
    Acute appendicitis in leukaemia patients undergoing haematopoietic stem cell transplantation during the neutropaenic phase: a case series from a single BMT centre in China.
    Bone Marrow Transplant. 2018;53:219-222.
    PubMed    


  633. NYGAARD M, Andersen NS, Moser CE, Olesen G, et al
    Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival.
    Bone Marrow Transplant. 2018 Feb 1. pii: 10.1038/s41409-018-0099.
    PubMed     Abstract available


    January 2018
  634. PATHAK M, Diep PP, Lai X, Brinch L, et al
    Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0090.
    PubMed     Abstract available


  635. TURCOTTE LM, Wang T, Hemmer MT, Spellman SR, et al
    Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0100.
    PubMed    


  636. BADER P, Kuci Z, Bakhtiar S, Basu O, et al
    Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-018-0102.
    PubMed     Abstract available


  637. APITHY MJ, Charbonnier A, Desoutter J, Diouf M, et al
    Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0083.
    PubMed    


  638. CALBI V, Fumagalli F, Consiglieri G, Penati R, et al
    Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0085.
    PubMed    


  639. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-017-0082.
    PubMed    


  640. COLTOFF A, Lancman G, Kim S, Steinberg A, et al
    Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0094.
    PubMed    


  641. ALHASHIM N, Aljurf M, Hassanein M, Chaudhri N, et al
    Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0093.
    PubMed     Abstract available


  642. MOHAMMED J, Akomolafe T, Aljurf M, Savani B, et al
    'To treat or not to treat': raising awareness on the effects of graft versus host disease drugs on musculoskeletal system.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0095.
    PubMed    


  643. WOLFF D, Greinix H, Lee SJ, Gooley T, et al
    Biomarkers in chronic graft-versus-host disease: quo vadis?
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0092.
    PubMed     Abstract available


  644. VAN DEN BRINK M, Uhrberg M, Jahn L, DiPersio JF, et al
    Selected biological issues affecting relapse after stem cell transplantation: role of T-cell impairment, NK cells and intrinsic tumor resistance.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0078.
    PubMed     Abstract available


  645. KOTCHETKOV R, Dyszkiewicz-Korpanty A, Kukreti V
    Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0080.
    PubMed    


  646. SAITO H, Ito M, Kato S, Kodera Y, et al
    The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0084.
    PubMed     Abstract available


  647. MERKER M, Meister MT, Rettinger E, Jarisch A, et al
    Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0088.
    PubMed    


  648. KHOURY HJ, Langston AA, Kota VK, Wilkinson JA, et al
    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0081.
    PubMed     Abstract available


  649. JIMENEZ-UBIETO A, Grande C, Caballero D, Yanez L, et al
    Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-018-0096.
    PubMed    


  650. ROBERT S, Albring JC, Frebel K, Opitz C, et al
    Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-017-0071.
    PubMed     Abstract available


  651. LAHOUD OB, Moskowitz AJ, Horwitz SM, Giralt SA, et al
    Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-017-0086.
    PubMed    


  652. DIEP PP, Melberg HO, Brinch L, Buechner J, et al
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-018-0091.
    PubMed    


  653. MOHAMMED J, AlGhamdi A, Hashmi SK
    Full-body physical therapy evaluation for pre- and post-hematopoietic cell transplant patients and the need for a modified rehabilitation musculoskeletal specific grading system for chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 18. pii: 10.1038/s41409-017-0075.
    PubMed    


  654. FRANGOUL H, Evans M, Isbell J, Bruce K, et al
    Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0077.
    PubMed    


  655. BAYDOUN M, Barton DL
    Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0073.
    PubMed     Abstract available


  656. ROBINSON SP, Boumendil A, Finel H, Peggs KS, et al
    Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0067.
    PubMed     Abstract available


  657. HUO MR, Pei XY, Li D, Chang YJ, et al
    Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0072.
    PubMed     Abstract available


  658. CALORE E, Marzollo A, Cananzi M, Pizzi M, et al
    Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0065.
    PubMed    


  659. SCHUMACHER H, Stuwe S, Kropp P, Diedrich D, et al
    A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0070.
    PubMed     Abstract available


  660. REDDIVALLA N, Robinson AL, Reid KJ, Radhi MA, et al
    Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoetic stem cell transplant.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0064.
    PubMed     Abstract available


  661. SHICHIJO T, Fuji S, Tajima K, Kubo H, et al
    Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0045.
    PubMed    


  662. WALLACE G, Myers KC, Teusink-Cross A, Davies SM, et al
    Topical vitamin D analog for chronic graft versus host disease of the skin.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0031.
    PubMed    


  663. SCHMALBROCK LK, Bonifacio L, Bill M, Jentzsch M, et al
    Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0060.
    PubMed    


  664. GAUTHIER J, Poire X, Gac AC, Leclerc M, et al
    Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0018.
    PubMed     Abstract available


  665. KATZ MC, Michaelis S, Siegmund DM, Koch R, et al
    Association analysis between SUFU polymorphism rs17114808 and acute graft versus host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0059.
    PubMed    


  666. FERREIRA AM, Pontes da Silva CA, Pereira AD, Szor RS, et al
    Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0068.
    PubMed    


  667. HAYASHI H, Ruggeri A, Volt F, Cornelissen JJ, et al
    Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0061.
    PubMed    


  668. JONES L, Dandoy C, Jodele S, Myers KC, et al
    Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0041.
    PubMed    


  669. LIU Y, Xu L, Zhang X, Wang Y, et al
    Acute kidney injury following haplo stem cell transplantation: incidence, risk factors and outcome.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0030.
    PubMed    


  670. CHEN Y, Lu J, Xu LP, Chen H, et al
    Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0069.
    PubMed    


  671. OLIVIERI J, Attolico I, Nuccorini R, Pascale SP, et al
    Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0051.
    PubMed     Abstract available


  672. OGAWA H, Ikegame K, Daimon T, Uchida N, et al
    Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0028.
    PubMed    


  673. FERNANDES JF, Bonfim C, Kerbauy FR, Rodrigues M, et al
    Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0015.
    PubMed     Abstract available


  674. DEVILLIER R, Labopin M, Chevallier P, Ledoux MP, et al
    Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Ma
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0043.
    PubMed     Abstract available


  675. SCHOEMANS HM, Goris K, Van Durm R, Vanbrabant K, et al
    Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0017.
    PubMed    


  676. MAYER K, Schumacher M, Eis-Hubinger AM, Pietzonka S, et al
    Intravesical cidofovir application in BK virus cystitis after allogeneic hematopoetic stem cell transplantation (HSCT) is safe and highly effective.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0044.
    PubMed    


    December 2017
  677. JUDET A, Copie-Bergman C, Zemoura L, Catherinot E, et al
    Epithelial chimerism in lung tissue after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0050.
    PubMed    


  678. FALCONE U, Jiang H, Bashir S, Tsang R, et al
    Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0054.
    PubMed    


  679. DEOTARE U, Atenafu EG, Loach D, Michelis FV, et al
    Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0053.
    PubMed    


  680. MITRUS I, Smagur A, Fidyk W, Czech M, et al
    Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0056.
    PubMed     Abstract available


  681. SEE WQ, Tung JY, Cheuk DK, Hwang YY, et al
    Endocrine complications in patients with transfusion-dependent thalassaemia after haemopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0052.
    PubMed    


  682. KUSKONMAZ B, Ayvaz D, Tezcan I, Yuce A, et al
    Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0040.
    PubMed    


  683. DIROU S, Chambellan A, Chevallier P, Germaud P, et al
    Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0057.
    PubMed     Abstract available


  684. LOPEZ-INIGUEZ A, Carrera-Villanueva KA, Leon-Rodriguez E, Cuellar-Rodriguez J, et al
    Recurrent arthritis and immune reconstitution inflammatory syndrome in hematopoietic stem cell transplantation (HSCT).
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0058.
    PubMed    


  685. RAGON BK, Mehta RS, Gulbis AM, Saliba RM, et al
    Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0034.
    PubMed     Abstract available


  686. SWEISS K, Anderson J, Wirth S, Oh A, et al
    A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0024.
    PubMed     Abstract available


  687. SIDANA S, Tandon N, Gertz MA, Dispenzieri A, et al
    Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0020.
    PubMed     Abstract available


  688. NGUYEN VP, Brauneis D, Kaku M, Sloan JM, et al
    Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0048.
    PubMed    


  689. VAN GORKOM G, van Gelder M, Eikema DJ, Blok HJ, et al
    Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
    Bone Marrow Transplant. 2017 Dec 18. pii: 10.1038/s41409-017-0023.
    PubMed     Abstract available


  690. UHM J, Shin E, Michelis FV, Thyagu S, et al
    Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
    Bone Marrow Transplant. 2017 Dec 15. pii: 10.1038/s41409-017-0025.
    PubMed    


    November 2017
  691. LEHRER J, Brissot E, Ruggeri A, Dulery R, et al
    Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study.
    Bone Marrow Transplant. 2017 Nov 20. doi: 10.1038/bmt.2017.
    PubMed    


  692. FAROWSKI F, Bucker V, Vehreschild JJ, Biehl L, et al
    Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  693. CROCCHIOLO R, Ringden O, Bay JO, Blaise D, et al
    Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  694. CHAKRABORTY R, Muchtar E, Kumar SK, Buadi FK, et al
    Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  695. DOWLING MR, Li S, Dey BR, McAfee SL, et al
    Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


    October 2017
  696. ALBERT E, Solano C, Gimenez E, Focosi D, et al
    The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  697. SIVARAJ D, Bacon W, Long GD, Rizzieri DA, et al
    High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  698. SHIN DY, Lee JH, Park S, Lee JO, et al
    Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  699. JEKER B, Novak U, Mansouri Taleghani B, Baerlocher GM, et al
    NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  700. O'DWYER DN, Duvall AS, Xia M, Hoffman TC, et al
    Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  701. SHANIS D, Anandi P, Grant C, Bachi A, et al
    Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  702. MICHNIACKI TF, Mulcahy Levy JM, Quinones RR, Giller RH, et al
    Successful correction of familial hemophagocytic lymphohistiocytosis using prenatal genetic testing and preemptive hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed    


  703. JOFFE E, Rosenberg D, Rozovski U, Perry C, et al
    Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  704. KANSAGRA A, Inwards DJ, Ansell SM, Micallef IN, et al
    Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  705. GOLDSMITH SR, Slade M, DiPersio JF, Westervelt P, et al
    Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  706. FOUZIA NA, Edison ES, Lakshmi KM, Korula A, et al
    Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  707. HEMMATI PG, Pfeifer K, Vuong LG, Jehn CF, et al
    Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed    


  708. YOSHIMURA K, Yano I, Yamamoto T, Kawanishi M, et al
    Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  709. GERULL S, Denhaerynck K, Chalandon Y, Halter JP, et al
    Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed    


  710. CHO C, Hsu M, Barba P, Maloy MA, et al
    Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  711. RE A, Gini G, Rupolo M, Levis A, et al
    Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed    


  712. KROGER N, Bishop M, Giralt S, Wayne A, et al
    Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed    


  713. KHOSLA J, Yeh AC, Spitzer TR, Dey BR, et al
    Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  714. GALIENI P, Troiani E, Bigazzi C, Mazzotta S, et al
    Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed    


  715. LIU C, Frank DN, Horch M, Chau S, et al
    Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


    September 2017
  716. MONTEFUSCO V, Mussetti A, Rezzonico F, Maura F, et al
    Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  717. ALMICI C, Skert C, Bruno B, Bianchetti A, et al
    Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  718. SCHEID C, de Wreede L, van Biezen A, Koenecke C, et al
    Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


  719. KUBA K, Esser P, Mehnert A, Johansen C, et al
    Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Abstract available


    May 2017
  720. MALLHI K, Orchard PJ, Miller WP, Cao Q, et al
    Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.
    Bone Marrow Transplant. 2017;52:726-732.
    PubMed     Abstract available


    January 2017
  721. HAVERKOS BM, Huang Y, Elder P, O'Donnell L, et al
    A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Abstract available


    February 2016
  722. MASOURIDI-LEVRAT S, Simonetta F, Beauverd Y, Tsopra O, et al
    Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2015.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: